0001193125-23-163039.txt : 20230608 0001193125-23-163039.hdr.sgml : 20230608 20230608074533 ACCESSION NUMBER: 0001193125-23-163039 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20230608 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230608 DATE AS OF CHANGE: 20230608 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO Co plc CENTRAL INDEX KEY: 0001585364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36353 FILM NUMBER: 231000741 BUSINESS ADDRESS: STREET 1: THE SHARP BUILDING STREET 2: HOGAN PLACE CITY: DUBLIN 2 STATE: L2 ZIP: D02 TY74 BUSINESS PHONE: 269-673-8451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 FORMER COMPANY: FORMER CONFORMED NAME: PERRIGO Co Ltd DATE OF NAME CHANGE: 20130828 8-K 1 d505583d8k.htm 8-K 8-K
PERRIGO Co plc 00-0000000 1 false 0001585364 0001585364 2023-06-08 2023-06-08 0001585364 prgo:OrdinaryShares0001ParValueMember 2023-06-08 2023-06-08 0001585364 prgo:A39SeniorNoteDue2024Member 2023-06-08 2023-06-08 0001585364 prgo:M4.375NotesDue2026Member 2023-06-08 2023-06-08 0001585364 prgo:A313SeniorNoteDue2030Member 2023-06-08 2023-06-08 0001585364 prgo:M5.300NotesDue2043Member 2023-06-08 2023-06-08 0001585364 prgo:M4.900NotesDue2044Member 2023-06-08 2023-06-08

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

June 8, 2023

 

 

Perrigo Company plc

(Exact name of registrant as specified in its charter)

 

 

Commission file number 001-36353

 

Ireland   Not Applicable

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

The Sharp Building, Hogan Place, Dublin 2, Ireland D02 TY74

+353 1 7094000

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities Registered pursuant to section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Ordinary shares, €0.001 par value   PRGO   New York Stock Exchange
3.900% Notes due 2024   PRGO24   New York Stock Exchange
4.375% Notes due 2026   PRGO26   New York Stock Exchange
4.400% Notes due 2030   PRGO30   New York Stock Exchange
5.300% Notes due 2043   PRGO43   New York Stock Exchange
4.900% Notes due 2044   PRGO44   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 8, 2023, Perrigo Company plc (“Perrigo” or the “Company”) announced the appointment of Mr. Patrick Lockwood-Taylor, 54, as President, CEO and director, effective June 30, 2023, following the retirement of Murray Kessler from those same positions on the same day. Mr. Kessler will remain with the Company in an advisory role to assist in the transition until July 31, 2023.

Mr. Lockwood-Taylor joins Perrigo from Bayer AG, where he served in dual roles of Regional President of Consumer Health North America since August 2018 and President of the about $15 billion revenue Bayer U.S. business since August 2020. Prior to joining Bayer, Mr. Lockwood-Taylor served as President and CEO of The Oneida Group, a private company that manufactures tabletop and food preparation products for the consumer, foodservice, and specialty markets, from May 2016 to August 2018. Prior to this, Mr. Lockwood-Taylor held various positions of increasing responsibility at Procter & Gamble for more than 20 years, including brand franchise and general management leadership positions. During his tenure as Senior Vice President for Procter and Gamble’s Personal Health Care business, he also served as Chair of the Consumer Health Products Industry Association (CHPA). In total, Mr. Lockwood-Taylor’s career spans more than 25 years of experience in global consumer product leadership roles, including positions in operations management, sales, marketing, country management and general management across four continents. Mr. Lockwood-Taylor earned first class joint honors degrees in economics and management studies from Leeds University, and a Professional Diploma in Marketing from the Chartered Institute of Marketing.

In connection with his appointment, the Company, through its US subsidiary Perrigo Company, a Michigan corporation, entered into an employment agreement with Mr. Lockwood-Taylor on June 5, 2023 to be effective on June 30, 2023, pursuant to which he is appointed CEO, President and member of the Board (the “Employment Agreement”). The Employment Agreement has an initial term of two years, which is subject to automatic renewal thereafter for two-year periods unless either party provides 90 days’ prior notice of non-renewal. The Employment Agreement provides that Mr. Lockwood-Taylor will be entitled to an annual base salary of $1,200,000 and a target annual bonus opportunity of no less than 120% of his annual base salary (the “Target Annual Bonus”), provided however, in respect of calendar year 2023, he will not receive a pro-rated Annual Bonus and will instead be eligible to receive a full Annual Bonus, based on the achievement of pre-established performance goals and evaluation of his performance. The actual amount of the annual bonus will range from 0% to 200% of the Target Annual Bonus; provided that Mr. Lockwood-Taylor will receive at least 50% of the Target Annual Bonus if the minimum applicable performance metrics are achieved for the applicable fiscal year. He will also be eligible to participate in the Company’s 2019 Long-Term Incentive Plan; provided that annual grants made to Mr. Lockwood-Taylor beginning in 2024 shall have a grant date fair value of at least $5,600,000. Mr. Lockwood-Taylor will also receive a sign-on award of performance stock units based on adjusted operating income from 2023-2025 with a grant date fair value of $1,500,000 (the “Sign-On PSUs”) and a sign-on award of restricted stock units with a grant date fair value of $2,800,000, which shall vest in three equal annual installments (the “Sign-On RSUs”). Mr. Lockwood-Taylor will participate in employee benefit plans in effect from time to time and is also eligible for relocation benefits pursuant to the Company’s relocation policy, including a lump sum miscellaneous payment of $20,000. In the event the Company delivers a notice of non-renewal or Mr. Lockwood-Taylor’s is terminated without cause or resigns for good reason (each as defined in the Employment Agreement), the Sign-On RSUs will continue to vest on schedule and the Sign-On PSUs shall continue to vest based upon actual performance over the relevant period. In addition, the Employment Agreement entitles Mr. Lockwood-Taylor to indemnification to the fullest extent permitted by applicable law and directors’ and officers’ insurance coverage, in each case, to the same extent as other officers and directors of Perrigo.

If Mr. Lockwood-Taylor’s employment were terminated involuntarily by the Company without cause or by Mr. Lockwood-Taylor for good reason, in either case, other than upon, or within 24 months following, a change in control, he will be entitled to a prorated annual bonus for the year of termination (determined based on actual performance), cash severance equal to 1.5 times the sum of his annual base salary and target annual bonus opportunity, and payment of the cost of health care continuation


coverage for up to 18 months following termination, plus up to an additional six months. Mr. Lockwood-Taylor will also be entitled to the continued vesting of any then-outstanding equity incentive awards (other than the Sign-On PSUs, Sign-On RSUs and annual grants made to Mr. Lockwood-Taylor under the 2019 Long-Term Incentive Plan in 2024 and 2025, which will continue to vest as described above) for 24 months following his termination (pro-rated for any vesting period that ends after the end of such 24 month period), with any performance-based awards vesting, if at all, based on actual performance.

If Mr. Lockwood-Taylor’s employment were terminated involuntarily by the Company without cause or by Mr. Lockwood-Taylor for good reason, in either case, upon, or within 24 months following, a change in control, he would be entitled to substantially the same benefits as described above, except that he will receive an additional lump sum cash payment in an amount equal to the cost of healthcare continuation coverage for six months following termination, and the cash severance payment would be equal to two times the sum of his annual base salary and target annual bonus opportunity. Mr. Lockwood-Taylor will also be entitled to the full vesting of any then-outstanding equity incentive awards (including, but not limited to, the Sign-On PSUs and Sign-On RSUs), with any then-outstanding performance-based equity incentive awards vesting based on “target” levels of achievement of the applicable performance thresholds.

The foregoing severance benefits are subject to Mr. Lockwood-Taylor’s execution of a release of claims in favor of Perrigo. In addition, Mr. Lockwood-Taylor has agreed to comply with (i) a post-termination noncompete covenant and a post-termination nonsolicitation of customers and employees covenant, each of which will endure for 24 months following any termination of employment, (ii) a perpetual confidentiality covenant, and (iii) a perpetual mutual nondisparagement covenant.

The foregoing summary of the Employment Agreement is qualified in its entirety by the full text thereof and the Forms of Restricted Stock Unit Award Agreements, which are filed as Exhibits 10.1, 10.2 and 10.3, respectively to this Current Report on Form 8-K, and are incorporated herein by reference.

 

ITEM 9.01.

Financial Statements and Exhibits

(d) Exhibits

 

Exhibit

Number

  

Description

10.1    Employment Agreement, effective as of June 30, 2023, by and between Perrigo Company and Patrick Lockwood-Taylor
10.2    Form of Restricted Stock Unit Award Agreement (Performance Based) under the Perrigo Company plc 2019 Long-Term Incentive Plan
10.3    Form of Restricted Stock Unit Award Agreement (Service Based) under the Perrigo Company plc 2019 Long-Term Incentive Plan
104    Cover Page Interactive Data file (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    (Registrant)
    PERRIGO COMPANY PLC
    By:  

/s/ Eduardo Bezerra

Dated: June 8, 2023       Eduardo Bezerra
      Chief Financial Officer
EX-10.1 2 d505583dex101.htm EX-10.1 EX-10.1

Exhibit 10.1

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into, as of June 5, 2023 with employment commencing on June 30, 2023 (the “Effective Date”) by and between Perrigo Company, a Michigan corporation (the “Company”), and Patrick Lockwood-Taylor (“Executive”).

WHEREAS, the Company desires to employ Executive as its Chief Executive Officer and President;

WHEREAS, the Executive desires to be employed as the Chief Executive Officer and President of the Company; and

WHEREAS, the Company and Executive desire to enterer into the Agreement to set forth the terms of Executive’s Service to the Company; and

NOW THEREFORE, in consideration of the foregoing, the mutual promises contained herein and other good and valuable consideration, the receipt and sufficiency of which are acknowledged, the parties agree as follows:

1. Employment Period. The Company agrees to employ Executive, and Executive agrees to serve the Company and its Affiliates (as defined below), subject to the terms and conditions of this Agreement, for the period commencing on the Effective Date and ending the second anniversary of the Effective Date (the “Employment Period”). Thereafter, unless previously terminated, the Employment Period shall be automatically extended for consecutive periods of two years unless either party provides written notice to the other party that the Employment Period will not be extended (a “Non-Renewal”) in accordance with Section 11(b) (a “Notice of Non-Renewal”) not less than 90 days prior to the end of the Employment Period as then in effect. Notwithstanding the foregoing, (a) upon a “Change in Control” (as defined in the Perrigo Company plc Change in Control Severance Policy for U.S. Employees, as amended and restated effective of February 13, 2019 (the “CiC Policy”)), the Employment Period shall automatically be extended until the second anniversary of the date such Change in Control is consummated (unless the Employment Period would otherwise expire after such date); and (b) the Employment Period shall immediately terminate upon any termination of Executive’s employment with the Company and its subsidiaries pursuant to Section 4. For purposes of this Agreement, the term “Affiliate” means an entity controlled by, controlling or under common control with Perrigo Company plc, a public limited company incorporated in Ireland (the Company’s ultimate parent entity) (“Parent”) or the Company (for the avoidance of doubt, the Company is an Affiliate of Parent and vice versa).

2. Position and Duties; Location; Standard of Services.

(a) Position and Duties. During the Employment Period, Executive shall serve as Chief Executive Officer and President of the Company and shall perform customary and appropriate duties as may be reasonably assigned to Executive from time to time by the Board of Directors of Parent (the “Board”). In connection with Executive’s employment by and service with the Company, as of the Effective Date, Executive shall (i) hold the titles of Chief Executive Officer and President of Parent, and (ii) serve as a director of the Board (subject to the provisions of Parent’s Memorandum and Articles of Association), in each case, without any additional compensation in respect thereof or the creation of an employment relationship with Parent. Executive shall have such responsibilities, power and authority as those normally associated with such positions in public companies of a similar stature. Executive shall report solely and directly to the Board.


(b) Location. During the Employment Period, from June 30, 2023, until September 30, 2023, Executive’s principal place of employment shall be Executive’s home in New Jersey. From October 1, 2023, through the remainder of the Employment Period, the Executive’s principal place of employment shall be the Company’s executive offices in Grand Rapids, Michigan, subject to reasonable business travel at the Company’s request; provided that the parties acknowledge that Executive will spend significant time in the Company’s offices in Ireland.

(c) Standard of Services. During the Employment Period, Executive agrees to devote Executive’s full business attention and time to the business and affairs of the Company and its Affiliates and to use Executive’s reasonable best efforts to perform faithfully and efficiently such responsibilities. Within 60 days after the Effective Date, Executive shall identify all boards of directors of for-profit entities on which he sits to the Nominating & Governance Committee of the Perrigo Company PLC Board of Directors for review and approval, and will resign from same if required by the Nominating & Governance Committee, and will follow the same process regarding any additional nominations for boards of directors of for-profit entities during the Employment Period. During the Employment Period, Executive may deliver lectures, fulfill speaking engagements, teach at educational institutions, manage personal investments and, subject to the prior written approval of the Board (or a committee thereof), which approval shall not be unreasonably withheld, serve on civic, charitable or other not-for-profit or for-profit boards or committees (collectively, the “Other Activities”), in each case, so long as such Other Activities do not materially interfere with the performance of Executive’s responsibilities in accordance with this Agreement and Executive complies with applicable provisions of any codes of business conduct and ethics of the Company and its Affiliates, as in effect from time to time. For avoidance of doubt, Executive’s engagement in the Other Activities in accordance with this Section 2(c) shall not be deemed a violation of the foregoing requirement that Executive shall devote his full business attention and time to the business and affairs of the Company and its Affiliates and use his reasonable best efforts to perform faithfully and efficiently such responsibilities.

3. Compensation and Employee Benefits.

(a) Annual Base Salary. During the Employment Period, Executive shall receive an annual base salary (the “Annual Base Salary”) of $1,200,000 payable in accordance with the Company’s regular payroll practices, but no less frequently than monthly. The Annual Base Salary shall be reviewed periodically by the Board or an appropriate committee thereof (the Board or such committee, the “Committee”) for possible increase, as determined in the sole and absolute discretion of the Committee, pursuant to the normal performance review policies for senior executives of the Company. Notwithstanding the above, the Committee may decrease the Annual Base Salary in a proportion (not greater than 10%) that generally applies to other senior executives of the Company in connection with an across-the-board senior executive salary decrease as a result of adverse business conditions, so long as such reduction ceases upon the cessation of such adverse business conditions; provided, that the foregoing ability to decrease the Annual Base Salary shall cease to apply upon a Change in Control. The term “Annual Base Salary” as used in this Agreement shall refer to the Annual Base Salary as it may be so adjusted from time to time.

 

2


(b) Annual Bonus. During the Employment Period, Executive shall have the opportunity to earn, for each fiscal year of the Company, an annual bonus (the “Annual Bonus”) pursuant to the terms of the annual incentive bonus plan (the “AIP”) in which the Company’s senior executives participate, as in effect from time to time. Executive’s target Annual Bonus opportunity shall be no less than 120% of the Annual Base Salary (the “Target Annual Bonus”); provided, however, in respect of calendar year 2023, Executive will not receive a pro-rated Annual Bonus and will instead be eligible to receive a full Annual Bonus, based on the achievement of pre-established performance goals and its evaluation of Executive’s performance (together, the “Bonus Performance Metrics”). The actual amount of the Annual Bonus may range from 0% to 200% of the Target Annual Bonus, as determined by the Committee on the same basis as determinations made with respect to other senior executives of the Company, based on the achievement of pre-established performance goals and its evaluation of Executive’s performance (together, the “Bonus Performance Metrics”); provided, that Executive will be eligible to receive an Annual Bonus equal to no less than 50% of the Target Annual Bonus in the event that the minimum Bonus Performance Metrics for the applicable fiscal year are achieved. Each Annual Bonus that Executive earns pursuant to the applicable Bonus Performance Metrics shall be paid to Executive at the same time as the Company otherwise pays annual bonuses to senior executives of the Company for the applicable fiscal year. Except as provided in Section 5(a), (b), (c), or (d), as applicable, the Annual Bonus shall be subject to Executive being employed on the date of payment of the Annual Bonus for the applicable year. The Annual Bonus shall not be considered an acquired right of Executive, even if it is paid on a repeated basis.

(c) Long-Term Incentive Awards. Executive will be eligible to participate in Parent’s 2019 Long-Term Incentive Plan, as amended (the “2019 LTIP”), on terms and conditions as determined in the sole and absolute discretion of the Committee; provided; that, beginning with the 2024 annual grant, the annual grants shall (i) be on the same terms and conditions (including the form and mix of grant types) as, and granted to Executive at the same time as such awards are granted to, other members of the Company’s operating committee, and (ii) have a grant date fair value of not less than $5,600,000. During the Employment Period, Executive shall also be eligible to participate in other long-term cash and equity incentive plans, practices, policies, and programs applicable generally to other senior executives of the Company, as determined by the Committee in its sole and absolute discretion.

(d) Buy-Out Compensation.

(i) 2023 One-Time Equity Restricted Stock Unit (“RSU”) Grant – Upon commencement and within thirty (30) days of the Effective Date, Executive shall receive an award of RSUs with grant-date fair value in the amount of $2,800,000, which shall vest in three approximately equal annual installments on the first, second, and third anniversaries of the grant date, subject to the terms and conditions of the 2019 LTIP and the grant agreement, which will provide for continued vesting of any unvested RSUs if the Company timely files a notice of Non-Renewal of this Agreement or terminates the Executive without Cause, or if the Executive terminates employment for Good Reason.

 

3


(ii) 2023 One-Time Equity Performance Stock Unit (“PSU”) Grant – Upon commencement and within 30 days of the Effective Date, Executive shall receive an award of PSUs with target grant-date fair value of $1,500,000. The award will be separated into three tranches, each of which may be earned from 0 to 200% of the target number of PSUs, based on the Company’s Adjusted Operating Income (OI) performance versus the same annual Adjusted OI goals as are used for the 2023-2025 Adjusted Operating Income PSUs (“2023-2025 OI PSUs”). Any earned shares from the 2023 tranche will vest one year from the grant date; any earned shares from the 2024 and 2025 tranches will vest upon the Committee’s certification of the 2024 and 2025 Adjusted Operating Income performance, subject to the terms and conditions of the 2019 LTIP and the grant agreement , which will provide for continued vesting of any unvested PSUs if the Company timely files a notice of Non-Renewal of this Agreement or terminates the Executive without Cause, or if the Executive terminates employment for Good Reason.

(e) Other Employee Benefit Plans; Perquisites; Vacation. During the Employment Period, Executive shall be entitled to the perquisites, and to participate in the employee benefit plans, practices, policies and programs, in each case, as in effect from time to time, and that are generally applicable to other senior executives of the Company (including, but not limited to, retirement, deferred compensation and health and welfare benefits) on the same terms as are applicable to other senior executives of the Company. In addition, during the Employment Period, Executive shall be eligible for five weeks of vacation per calendar year, or such greater amount of time as is determined in accordance with the Company’s vacation policy as in effect from time to time, and in all cases subject to the terms of such policy.

(f) Relocation Policy. Executive shall be entitled to receive the benefits and/or reimbursements for relocation costs related to Executive’s relocation to the Grand Rapids, Michigan area, in each case, payable pursuant to the Company’s relocation policy. This includes a one-time miscellaneous lump sum in the amount of $20,000 to be paid within thirty (30) days of the Effective Date.

(g) Temporary Housing Expenses. For a period of three (3) months from the Effective Date, Executive shall be reimbursed (i) on a monthly basis for the reasonable costs incurred by Executive in obtaining temporary housing in the vicinity of the Company’s offices in Grand Rapids, Michigan.

(h) Business Expenses. During the Employment Period, and in addition to Executive’s reimbursement rights pursuant to Section 3(f), Executive shall be entitled to receive prompt reimbursement for all reasonable business expenses (including travel, entertainment, professional dues and subscriptions) incurred by Executive, in accordance with the Company’s policies as in effect from time to time

(i) Legal Fees. The Company will pay Executive’s legal counsel directly, upon presentation of customary invoices, for the fees and expenses incurred by Executive, in connection with the preparation and negotiation of this Agreement and the Exhibits hereto, up to a maximum of $50,000.

 

4


4. Termination of Employment.

(a) Death or Disability. Executive’s employment shall terminate automatically upon Executive’s death during the Employment Period. If the Board determines in good faith that the Disability of Executive has occurred during the Employment Period (pursuant to the definition of Disability set forth below), it may provide Executive with written notice in accordance with Section 11(b) of its intention to terminate Executive’s employment. In such event, Executive’s employment with the Company and its Affiliates shall terminate effective on the 30th day after Executive’s receipt of such notice (the “Disability Effective Date”), provided that, within the 30 days after such receipt, Executive shall not have returned to full-time performance of Executive’s duties. For purposes of this Agreement, “Disability” shall mean the absence of Executive from Executive’s duties with the Company and its Affiliates on a full-time basis for 90 consecutive days, or for 120 days (which need not be consecutive) within a 365-day period, as a result of incapacity due to mental or physical illness. For the avoidance of doubt, during any period when Executive is absent from duties with the Company and its Affiliates as a result of incapacity due to mental or physical illness, but prior to Executive’s termination of employment due to Disability, Executive shall remain an employee of the Company and shall continue to receive the Annual Base Salary and all employee benefits provided to Executive pursuant to this Agreement in accordance with the terms of this Agreement.

(b) Cause. The Company may terminate Executive’s employment during the Employment Period either with or without Cause. For purposes of this Agreement, “Cause” shall mean, as determined in the sole discretion of the Board:

(i) The commission by Executive of an act of dishonesty or breach of trust, that is willful and demonstrably and materially injurious to the business, financial condition or reputation of the Company or its Affiliates;

(ii) Executive’s conviction of, or entry of a plea of guilty or nolo contendere with respect to, a felony crime or a crime involving moral turpitude, fraud, forgery, embezzlement or similar conduct;

(iii) Executive’s willful failure to perform, substantially perform Executive’s material duties with the Company or its Affiliates (other than as a result of physical or mental illness, impairment or disability);

(iv) A willful and material breach by Executive of Executive’s obligations under this Agreement, including a material and willful breach of the restrictive covenants and confidentiality provisions set forth in Section 7;

(v) Executive’s engaging in misconduct involving moral turpitude to the extent that his credibility and reputation no longer conform to the standard of senior executives of the Company or its Affiliates; or

(vi) A failure to assist and cooperate with the Company or its Affiliates in connection with the defense or prosecution of any claim that may be made against or by the Company or its Affiliates, or in connection with any ongoing or future investigation or dispute or claim of any kind involving the Company or its Affiliates, including any proceedings before any arbitral, administrative, regulatory, judicial, legislative or other body or agency.

 

5


Executive will not be deemed to be discharged for Cause unless and until there is delivered to Executive a copy of a resolution duly adopted by the affirmative vote of not less than a majority of the entire membership of the Board (excluding Executive, if he is then a member of the Board), at a meeting called and duly held for such purpose, finding in good faith that Executive is guilty of the conduct set forth above and specifying the particulars thereof in detail. Following a Change in Control, any such determination by the Board shall be subject to de novo review by a court of law pursuant to the dispute provisions of Section 11(a).

(c) Good Reason. Executive’s employment may be terminated by Executive either with or without Good Reason. For purposes of this Agreement, “Good Reason” shall mean Executive’s voluntary resignation after any of the following actions are taken by the Company or any of its Affiliates without Executive’s written consent:

(i) A material diminution of Executive’s duties or responsibilities, authorities, powers or functions, including ceasing to be Chief Executive Officer of the Company or assignment of duties materially inconsistent with the position of Chief Executive Officer of the Company, other than during an extended absence due to mental or physical illness (as determined in good faith by the Board), so long as any such material diminution ceases upon Executive’s return to work following such extended absence;

(ii) A relocation in Executive’s principal place of employment that would result in Executive’s commute from his principal residence increasing by 30 miles or more; or

(iii) Any material breach of this Agreement by the Company, including any material reduction in Executive’s Annual Base Salary (other than as contemplated by Section 3(a)) or Target Annual Bonus.

In order to invoke a termination for Good Reason, Executive shall provide written notice to the Company of the existence of one or more of the conditions described in clauses (i) through (iii) within 90 days following Executive’s knowledge of the initial existence of such condition or conditions, specifying in reasonable detail the conditions constituting Good Reason, and the Company and its Affiliates shall have 30 days following receipt of such written notice (the “Cure Period”) during which they may remedy the condition. In the event that the Company and its Affiliates fail to remedy the condition constituting Good Reason during the applicable Cure Period, Executive’s “separation from service” (within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (collectively, with the regulations and other guidance promulgated thereunder, the “Code”)) must occur, if at all, within 30 days following such Cure Period in order for such termination as a result of such condition to constitute a termination for Good Reason.

(d) Notice of Termination. Any termination by the Company with or without Cause, or by Executive with or without Good Reason, shall be communicated by Notice of Termination to the other party hereto given in accordance with Section 11(b). For purposes of this Agreement, a “Notice of Termination” means a written notice that (i) indicates the specific termination provision

 

6


in this Agreement relied upon, (ii) if the termination is by the Company for Cause or by Executive for Good Reason, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive’s employment under the provision so indicated and (iii) specifies the Date of Termination (as defined below), which date shall not be more than 30 days after the delivery of such notice (except in the case of a Notice of Non-Renewal that is deemed a Notice of Termination in accordance with the following sentence, in which case the Date of Termination shall be the date on which the Employment Period expires pursuant to Section 1). For the avoidance of doubt, a Notice of Non-Renewal delivered pursuant to Section 1 will be deemed to be a Notice of Termination and the expiration of the Employment Period following a Non-Renewal will be a termination of Executive’s employment either by the Company without Cause (if the Company delivers the Notice of Non-Renewal), or by Executive without Good Reason (if Executive delivers the Notice of Non-Renewal).

(e) Date of Termination. “Date of Termination” means (i) if Executive’s employment is terminated by the Company with or without Cause, or by Executive with or without Good Reason, the date of receipt of the Notice of Termination or any later date specified therein within 30 days following such notice (except that in the case of a termination by Executive without Good Reason, the Company may in its sole discretion change any such later date to a date of its choosing between the date of such receipt and such later date), (ii) if Executive’s employment is terminated by reason of death or Disability, the Date of Termination shall be the date of death of Executive or the Disability Effective Date, as the case may be, or (iii) if Executive’s employment is terminated by a Non-Renewal, the date on which the Employment Period expires pursuant to Section 1.

(f) Resignation from Other Positions. Upon the termination of Executive’s employment for any reason (unless otherwise agreed in writing by the Company and Executive), Executive shall be deemed to have resigned, without any further action by Executive, from any and all officer and director positions that Executive, immediately prior to such termination, (i) held with Parent, the Company or any of its Affiliates and (ii) held with any other entities at the direction of, or solely as a result of Executive’s affiliation with, the Company or any of its Affiliates. If for any reason this Section 4(f) is deemed to be insufficient to effectuate such resignations, then Executive shall, upon Parent’s or the Company’s request, execute any documents or instruments that Parent or the Company may deem necessary or desirable to effectuate such resignations. In addition, Executive hereby designates the Secretary or any Assistant Secretary of Parent or of any Affiliate to execute any such documents or instruments as Executive’s attorney-in-fact to effectuate such resignations if execution by the Secretary or any Assistant Secretary of Parent or any Affiliate is deemed by Parent or any Affiliate to be a more expedient means to effectuate such resignation or resignations.

5. Obligations of the Company upon Termination.

(a) Other than for Cause, Death or Disability; Company Non-Renewal; Resignation for Good Reason. If, during the Employment Period, the Company terminates Executive’s employment without Cause (other than due to death or Disability), there is a Non-Renewal as a result of the Company’s delivery of a Notice of Non-Renewal, or Executive terminates employment for Good Reason, in each case, other than upon or within 24 months following the consummation of a Change in Control (in which case Section 5(b) shall apply), then, subject to

 

7


Section 11(j) and to, in the case of clauses (ii), (iii), (iv), (v), and (vii) below, Executive’s execution within 50 days following the Date of Termination of a release of claims in the form attached as Exhibit A (the “Release”), which Release has become irrevocable in accordance with its terms (the date the Release becomes irrevocable, the “Release Effective Date”), the Company shall pay to Executive the following:

(i) the sum of (A) the portion of the Annual Base Salary due for the period through the Date of Termination to the extent not theretofore paid, and (B) Executive’s business expenses that have not been reimbursed by the Company as of the Date of Termination that were incurred by Executive prior to the Date of Termination in accordance with the applicable policy of the Company (the sum of the amounts described in clauses (A) and (B) shall be hereinafter referred to as the “Accrued Obligations”), which Accrued Obligations shall be paid in a lump sum in cash within 60 days following the Date of Termination;

(ii) any unpaid Annual Bonus earned by Executive in respect of the fiscal year of the Company that was completed on or prior to the Date of Termination (the “Unpaid Annual Bonus”), which Unpaid Annual Bonus shall be paid in a lump sum in cash on the first payroll date following the Release Effective Date (other than any portion of such Unpaid Annual Bonus that was deferred, which portion shall instead be paid in accordance with the applicable deferral arrangement and any election thereunder);

(iii) a prorated Annual Bonus in respect of the fiscal year of the Company in which the Date of Termination occurs, with such amount to equal the product of (A) the amount determined by the Committee based on actual performance for the fiscal year in which the Date of Termination occurs and otherwise on a basis no less favorable than the basis on which annual incentive award determinations are made by the Committee for other senior executives of the Company in respect of such fiscal year, and (B) a fraction, (I) the numerator of which is the number of days in the fiscal year of the Company in which the Date of Termination occurs through the Date of Termination, and (II) the denominator of which is 365 (the “Prorated Annual Bonus”), which Prorated Annual Bonus shall be paid on the date on which the Company otherwise pays annual bonuses to senior executives of the Company for such fiscal year (other than any portion of such Annual Bonus that was deferred, which portion shall instead be paid in accordance with the applicable deferral arrangement and any election thereunder);

(iv) an amount equal to the product of (A) 1.5 multiplied by (B) the sum of (x) the Annual Base Salary and (y) the Target Annual Bonus as in effect for the fiscal year of the Company in which the Date of Termination occurs, which amount shall be payable in a lump sum on the first payroll date following the Release Effective Date;

(v) if Executive elects health care continuation coverage under Section 4980B of the Code or other applicable law (“COBRA”) for himself and/or his eligible covered dependents equivalent to the coverage which they were receiving immediately prior to the Date of Termination, for 18 months following the Date of Termination, or such shorter period determined in accordance with clause (B) of this sentence (the “Continuation Period”), the Company shall pay the full premium cost of such coverage, based on the

 

8


prevailing rate (the “Prevailing COBRA Rate”) charged by the Company to persons who elect similar health care continuation coverage under COBRA (the “Health Care Benefits”); provided, however, that (A) the Health Care Benefits shall be reported by the Company as taxable income to Executive to the extent reasonably determined by the Company to be necessary to avoid the Health Care Benefits from being considered to have been provided under a discriminatory self-insured medical reimbursement plan pursuant to Section 105(h) of the Code, and (B) the Continuation Period shall cease at such time that Executive is eligible to receive health care benefits under another employer-provided plan (but no repayment of any previously-paid premium shall be required). In addition, the Company shall pay to Executive on the first day of each of the first six months following the expiration of the Continuation Period an amount in cash equal to the Prevailing COBRA Rate for the coverage for Executive and his eligible covered dependents which was in effect immediately prior to the expiration of the Continuation Period; provided, however, that no such payment shall be made following the time that Executive is eligible to receive health care benefits under another employer-provided plan;

(vi) to the extent not theretofore paid or provided, the Company shall timely pay or provide, in accordance with the terms of the applicable plan, program, policy, practice or contract, to Executive any other amounts or benefits required to be paid or provided or that Executive is eligible to receive under any plan, program, policy, practice or contract of the Company through the Date of Termination (such other amounts and benefits shall be hereinafter referred to as the “Other Benefits”); and

(vii) for purposes of any equity incentive awards granted to Executive following the effective date this Agreement (excluding, for the avoidance of doubt, any Buy-Out Compensation equity incentive awards granted to Executive following the Effective Date and the 2024 and 2025 Annual LTI grants), that remain outstanding on the Date of Termination, and notwithstanding anything to the contrary in the applicable award agreement, the 2019 LTIP, or any successor or similar plan, such equity incentive awards that would otherwise be scheduled to vest during the 24 months following the Date of Termination shall continue to vest during such 24-month period according to the vesting schedule in effect prior to the Date of Termination, unless the applicable award agreement, the 2019 LTIP, or any successor or similar plan provides for accelerated or continued vesting that is more favorable to Executive than the foregoing, in which case such more favorable provision shall apply in lieu of the foregoing. The Buy-Out Compensation equity award grant agreements and the 2024 and 2025 equity grant agreements shall provide for continued vesting of all unvested share units if the Company timely files a notice of Non-Renewal of this Agreement or terminates the Executive without Cause, or if the Executive terminates employment for Good Reason.

For the avoidance of doubt, if applicable, any amount payable pursuant to Section 5(a) shall be determined without regard to any reduction in compensation that resulted in Executive’s termination of employment for Good Reason. If Executive does not execute the Release within 50 days following the Date of Termination, or if Executive timely revokes the Release, Executive shall be entitled to only the compensation and benefits contemplated by Sections 5(a)(i) and (vi).

 

9


(b) Change in Control Termination. If, during the Employment Period, the Company terminates Executive’s employment without Cause (other than due to death or Disability), there is a Non-Renewal as a result of the Company’s delivery of a Notice of Non-Renewal, or Executive terminates employment for Good Reason, in each case, upon or within 24 months following the consummation of a Change in Control, then, subject to Section 11(j) and, in the case of all payments and benefits other than the Accrued Obligations and the Other Benefits, Executive’s execution within 50 days of the Date of Termination, and non-revocation, of the Release, the Company shall pay to Executive the following:

(i) the Accrued Obligations, the Unpaid Annual Bonus, the Health Care Benefits and the Other Benefits in accordance with the terms of Sections 5(a)(i), (ii), (v), and (vi), respectively;

(ii) a prorated Annual Bonus in respect of the fiscal year of the Company in which the Date of Termination occurs, with such amount to equal the product of (A) the Target Annual Bonus for the fiscal year in which the Date of Termination occurs, and (B) a fraction, (I) the numerator of which is the number of days that have elapsed in the fiscal year of the Company in which the Date of Termination occurs as of the Date of Termination, and (II) the denominator of which is 365 (the “Prorated Target Bonus”), which Prorated Target Bonus shall be paid in a lump sum in cash on the first payroll date following the Release Effective Date (other than any portion of such Annual Bonus that was deferred, which portion shall instead be paid in accordance with the applicable deferral arrangement and any election thereunder);

(iii) an amount equal to the product of (A) two multiplied by (B) the sum of (x) the Annual Base Salary and (y) the Target Annual Bonus as in effect for the fiscal year of the Company in which the Date of Termination occurs, payable in a lump sum on the first payroll date following the Release Effective Date;

(iv) a cash payment in an amount equal to six months’ health care premiums at the Prevailing COBRA Rate for Executive and each of his eligible dependents, payable in a lump sum on the first payroll date following the Release Effective Date; and

(v) for purposes of any equity incentive awards granted to Executive following the Effective Date, that remain outstanding on the Date of Termination, and notwithstanding anything to the contrary in the applicable award agreement, the 2019 LTIP, or any successor or similar plan, such equity incentive awards shall become fully vested (with any equity incentive awards that are subject to performance-based vesting criteria vesting at “target” levels of achievement).

For the avoidance of doubt, if applicable, any amount payable pursuant to Section 5(b) shall be determined without regard to any reduction in compensation that resulted in Executive’s termination of employment for Good Reason. If Executive does not execute the Release within 50 days following the Date of Termination, or if Executive revokes the Release, Executive shall be entitled to only the Accrued Obligations and the Other Benefits.

 

10


Other than as set forth in this Section 5(a) or 5(b), as applicable, in the event of a termination of Executive’s employment by the Company without Cause (other than due to death or Disability), due to a Non-Renewal as a result of the Company’s delivery of a Notice of Non-Renewal, or by Executive for Good Reason, the Company and its Affiliates shall have no further obligation to Executive under this Agreement.

(c) Death; Disability. If Executive’s employment is terminated by reason of Executive’s death or Disability during the Employment Period, this Agreement shall terminate without further obligations to Executive, other than for payment of the Accrued Obligations, the Unpaid Annual Bonus and the Prorated Annual Bonus and the timely payment or provision of the Other Benefits. The Accrued Obligations, the Unpaid Annual Bonus and the Prorated Annual Bonus shall be paid to Executive’s estate (in the event of death) or Executive or his legal representative (in the event of Disability), as applicable, on the same schedule as contemplated by Sections 5(a)(i)-(iii).

(d) Other Termination. If Executive’s employment is terminated during the Employment Period for a reason other than those governed by Section 5(a), (b), and (c) (including, for the avoidance of doubt, due to a Non-Renewal as a result of Executive’s delivery of a Notice of Non-Renewal), this Agreement shall terminate without further obligations to Executive under this Agreement, other than for (i) payment of the Accrued Obligations within 60 days following the Date of Termination and (ii) the timely payment or provision of the Other Benefits.

(e) Full Settlement. The payments and benefits provided under this Section 5 shall be in full satisfaction of the obligations of the Company and its Affiliates to Executive under this Agreement or any other plan, agreement, policy or arrangement of the Company and its Affiliates upon his termination of employment, and in no event shall Executive be entitled to severance pay or benefits beyond those specified in this Section 5 (for the avoidance of doubt, including the Perrigo Company plc U.S. Severance Policy, as amended and restated effective February 13, 2019, and the CiC Policy).

6. No Mitigation. In no event shall Executive be obligated to seek other employment or take any other action by way of mitigation of any amounts payable to Executive under Section 5 and such amounts shall not be reduced whether or not Executive obtains other employment.

7. Restrictive Covenants. In consideration for Executive’s continued employment and the compensation and benefits payable hereunder, Executive agrees to the covenants set forth below.

(a) Nondisclosure of Confidential Information.

(i) The parties agree that, during the course of Executive’s employment with the Company and its Affiliates, Executive has had and will continue to have access to, and has gained and will continue to gain knowledge with respect to, Confidential Information (as defined below). Executive agrees that Executive shall not, without the prior written consent of the Company, during the period of Executive’s employment with the Company and its Affiliates and thereafter for so long as it remains Confidential Information, use or disclose, or knowingly permit any unauthorized Person (as defined in Section 13(d) of the

 

11


Securities Exchange Act of 1934) to use, disclose or gain access to, any Confidential Information; provided, however, that Executive may disclose Confidential Information (x) as required by law or (y) as ordered by a court, provided that in any event described in the preceding clause (x) or (y), (A) Executive shall promptly notify the Company in writing, and consult with and assist the Company or its Affiliates in seeking a protective order or request for another appropriate remedy, (B) in the event that such protective order or remedy is not obtained, or if the Company waives compliance with the terms of the preceding clause (A), Executive shall disclose only that portion of the Confidential Information that, in the opinion of Executive’s legal counsel, is legally required to be disclosed and shall exercise reasonable best efforts to assure that confidential treatment shall be accorded to such Confidential Information by the receiving Person and (C) to the extent permitted by applicable law, the Company and its Affiliates shall be given an opportunity to review the Confidential Information prior to disclosure thereof.

(ii) Without limiting the foregoing, Executive agrees to keep confidential the existence of, and any information concerning, any dispute between Executive and the Company or any of its Affiliates, except that Executive may disclose information concerning such dispute to the court that is considering such dispute and to Executive’s legal counsel, provided that such counsel agrees not to disclose any such information other than as necessary to the prosecution or defense of such dispute.

(iii) For purposes of this Agreement, “Confidential Information” means information, observations and data concerning the business and affairs of the Company or any of its Affiliates, including all business information (whether or not in written form) that relates to the Company or any of its Affiliates, or their directors, officers, employees, customers, suppliers or contractors or any other third parties with respect to which the Company or any of its Affiliates has a business relationship or owes a duty of confidentiality, or their respective businesses or products, and that is not known to the public generally other than as a result of Executive’s breach of this Agreement, including technical information or reports; trade secrets; unwritten knowledge and “know how”; operating instructions; training manuals; customer lists; customer buying records and habits; product sales records and documents; product development, marketing and sales strategies; market surveys; marketing plans; profitability analyses; product cost; long-range plans; information relating to pricing, competitive strategies and new product development, including processes, formulas, designs, drawings, engineering and technology; information relating to any forms of compensation or other personnel-related information; contracts; and supplier lists. Confidential Information shall not include such information known to Executive prior to Executive’s involvement with the Company or any of its Affiliates or information rightfully obtained from a third party (other than pursuant to a breach by Executive of this Agreement or any other duty of confidentiality).

(iv) Nothing herein shall preclude (i) Executive’s right to communicate, cooperate or file a complaint with any European, U.S., national, federal, state or local governmental or law enforcement branch, agency or entity (collectively, a “Governmental Entity”) with respect to possible violations of any European, U.S., national, federal, state or local law or regulation, or otherwise make disclosures to any Governmental Entity, in each case, that are protected under the whistleblower or similar provisions of any such law or regulation; provided, that in each case such communications and disclosures are consistent with applicable law or (ii) Executive’s right to receive an award from a Governmental Entity for information provided under any whistleblower or similar program.

 

12


(b) Inventions and Patents. Executive agrees that all inventions, innovations, improvements, developments, methods, designs, analyses, drawings, reports and all similar or related information that relate to the actual or anticipated business, research and development or existing or future products or services of the Company or its Affiliates, and that are conceived, developed or made by Executive during his employment with the Company or its Affiliates (“Work Product”) belong to the Company and its Affiliates. Executive shall promptly disclose such Work Product to the Company and its Affiliates and perform all actions reasonably requested by the Company or its Affiliates (whether during or after the Employment Period) to establish and confirm such ownership (including assignments, consents, powers of attorney, and other instruments). To the fullest extent permitted by applicable law all intellectual property (including patents, trademarks, and copyrights) which are made, developed or acquired by Executive in the course of Executive’s employment with the Company or its Affiliates will be and remain the absolute property of the Company and its Affiliates, and Executive shall assist the Company and its Affiliates in perfecting and defending their rights to such intellectual property.

(c) Noncompetition. During Executive’s employment with the Company and its Affiliates and for the duration of the Restricted Period (as defined in this Section 7(c)), Executive shall not (i) directly or indirectly, without the prior written consent of the Company, engage in or invest as an owner, partner, stockholder, licensor, director, officer, agent or consultant for any Person that conducts a business that is in competition with a business conducted by the Company or any of its Affiliates anywhere in the world; or (ii) accept employment or an engagement for the provision of services in any capacity, including as an employee, director, consultant or advisor, directly or indirectly, with any Person that conducts a business that is in competition with a business conducted by the Company or any of its Affiliates anywhere in the world. For purposes hereof, conducting a business that is in competition with a business conducted by the Company or any of its Affiliates shall include the sale, manufacture, distribution or research and development of any product or service that is similar to a product or service sold, distributed, marketed or being researched or developed (including through a joint venture or investment in another entity) by the Company or any of its Affiliates, including store brand and value brand OTC drug or nutritional products, extended topical generic prescription pharmaceutical products, Company branded products, skin care products, women’s health products, CBD products, infant nutrition products and any other product or products that the Company or an Affiliate is marketing or actively planning to market during Executive’s employment with the Company and, with respect to the period after termination of employment, during the one-year period following the Date of Termination. Notwithstanding the foregoing, (iii) nothing in this provision shall prevent Executive from passively owning two percent (2%) or less of the outstanding securities of any class of any company listed on a national securities exchange or quoted on an automated quotation system.

For purposes of this Agreement, the term “Restricted Period” means in the event Executive’s employment is terminated for any reason and other than upon or within 24 months following the consummation of a Change in Control, the 24-month period immediately following the Date of Termination.

 

13


(d) Nonsolicitation of Clients. During Executive’s employment with the Company and its Affiliates and for the duration of the Restricted Period, Executive shall not, directly or indirectly, alone or in association with any other Person, without the prior written consent of the Company, (i) induce or attempt to induce any client, customer (whether former or current), supplier, licensee, franchisee, joint venture partner or other business relation of the Company or any of its Affiliates (collectively, “Clients”) to cease doing business with the Company or any such Affiliate, (ii) divert all or any portion of a Client’s business to any competitor of the Company or any such Affiliate, or (iii) in any way interfere with the relationship between any Client, on the one hand, and the Company or any such Affiliate, on the other hand.

(e) Nonsolicitation of Service Providers. During Executive’s employment with the Company and its Affiliates and for the duration of the Restricted Period, Executive shall not, directly or indirectly, without the prior written consent of the Company, (i) actively solicit, recruit or hire any Person who is at such time, or who at any time during the 12-month period prior to such solicitation or hiring had been, an employee or consultant of the Company or any of its Affiliates, (ii) solicit or encourage any employee of the Company or any of its Affiliates to leave the employment of the Company or any of its Affiliates or (iii) interfere with the relationship of the Company or any of its Affiliates with any Person or entity who or that is employed by or otherwise engaged to perform services for the Company or any of its Affiliates.

(f) Mutual Nondisparagement. From and following the Effective Date, Executive shall not make, either directly or by or through another Person, any oral or written negative, disparaging or adverse statements or representations of or concerning the Company or its Affiliates, any of their clients or businesses or any of their current or former officers, directors or employees. From and following the Effective Date, the Company shall not make, and shall direct its officers and directors not to make, either directly or by or through another Person, any oral or written negative, disparaging or adverse statements or representations of or concerning Executive. Notwithstanding the foregoing, subject to Section 7(a) in the case of Executive, nothing herein shall prohibit Executive, the Company, or the Company’s officers from (i) disclosing truthful information if legally required (whether by oral questions, interrogatories, requests for information or documents, subpoena, civil investigative demand or similar process), (ii) exercising any legally protected whistleblower rights (including pursuant to Rule 21F under the Securities Exchange Act of 1934), or (iii) in the case of Executive and the Company’s officers, providing honest assessments in the course of performing their employment duties in good faith.

(g) Return of Property. Executive acknowledges that all documents, records, files, lists, equipment, computer, iPad, mobile phone, software or other property (including intellectual property) relating to the businesses of the Company or any of its Affiliates, in whatever form (including electronic), and all copies thereof, that have been or are received or created by Executive while an employee of the Company or any of its Affiliates (including Confidential Information) are and shall remain the property of the Company and its Affiliates, and Executive shall immediately return such property to the Company upon the Date of Termination and, in any event, at the Company’s request. Notwithstanding the foregoing, Executive shall be permitted to retain at all times, including after the Date of Termination, copies of documents related to his personal compensation, including this Agreement, and copies of his contacts information and calendar. Executive further agrees that any property situated on the premises of, and owned by, the Company or any of its Affiliates, including disks and other storage media, filing cabinets or other work areas, is subject to inspection by the Company’s personnel at any time with or without notice.

 

14


(h) Remedies and Injunctive Relief. Executive acknowledges that a violation by Executive of any of the covenants contained in this Section 7 would cause irreparable damage to the Company and its Affiliates in an amount that would be material but not readily ascertainable, and that any remedy at law (including the payment of damages) would be inadequate. Accordingly, Executive agrees that, notwithstanding any provision of this Agreement to the contrary, in addition to any other damages it is able to show, the Company and its Affiliates shall be entitled (without the necessity of showing economic loss or other actual damage) to injunctive relief (including temporary restraining orders, preliminary injunctions and permanent injunctions), without posting a bond, in any court of competent jurisdiction for any actual or threatened breach of any of the covenants set forth in this Section 7 in addition to any other legal or equitable remedies it may have. In addition, in the event of Executive’s Willful Restrictive Covenant Breach (as defined in this Section 7(h)), the Company and its Affiliates shall be entitled to cease payment of the compensation and benefits contemplated by Section 5 to the extent not previously paid or provided (including ceasing vesting of outstanding equity incentive awards, but excluding the Accrued Obligations and Other Benefits), and to the prompt return by Executive of any portion of such compensation and the value of such benefits previously paid or provided (including forfeiture of any equity incentive awards that vested pursuant to Section 5 or the repayment of the value of any equity incentive awards that vested pursuant to Section 5 that have been exercised or settled, as applicable). For purposes of this Agreement, “Willful Restrictive Covenant Breach” means Executive’s material breach of any of the covenants set forth in this Section 7 which Executive knew, or with due inquiry, should have known, would constitute such a material breach. The preceding sentences of this Section 7(h) shall not be construed as a waiver of the rights that the Company and its Affiliates may have for damages under this Agreement or otherwise, and all such rights shall be unrestricted. The Restriction Period shall be tolled during (and shall be deemed automatically extended by) any period during which Executive is in violation of the provisions of Section 7(c), (d) or (e), as applicable. In the event that a court of competent jurisdiction determines that any provision of this Section 7 is invalid or more restrictive than permitted under the governing law of such jurisdiction, then, only as to enforcement of this Section 7 within the jurisdiction of such court, such provision shall be interpreted and enforced as if it provided for the maximum restriction permitted under such governing law.

(i) Acknowledgements.

(i) Executive acknowledges that the Company and its Affiliates have expended and will continue to expend substantial amounts of time, money and effort to develop business strategies, employee, customer and other relationships and goodwill to build an effective organization. Executive acknowledges that the Company and its Affiliates have a legitimate business interest in and right to protect its Confidential Information, goodwill and employee, customer and other relationships, and that the Company and its Affiliates could be seriously damaged by the disclosure of Confidential Information and the loss or deterioration of its employee, customer and other relationships. Executive further acknowledges that the Company and its Affiliates are entitled to protect and preserve the going concern value of the Company and its Affiliates to the extent permitted by law.

 

15


(ii) In light of the foregoing acknowledgments, Executive agrees that the covenants contained in this Agreement are reasonable and properly required for the adequate protection of the businesses and goodwill of the Company and its Affiliates. Executive further acknowledges that, although Executive’s compliance with the covenants contained in this Agreement may prevent Executive from earning a livelihood in a business similar to the business of the Company and its Affiliates, Executive’s experience and capabilities are such that Executive has other opportunities to earn a livelihood and adequate means of support for Executive and Executive’s dependents.

(iii) In light of the acknowledgements contained in this Section 7(i), Executive agrees not to challenge or contest the reasonableness, validity or enforceability of any limitations on, and obligations of, him contained in Section 7 of this Agreement.

8. Treatment of Certain Payments.

(a) Anything in this Agreement to the contrary notwithstanding, in the event the Accounting Firm (as defined below) shall determine that receipt of all Payments (as defined below) would subject Executive to the excise tax under Section 4999 of the Code, the Accounting Firm shall determine whether to reduce any of the Payments paid or payable pursuant to the Agreement (the “Agreement Payments”) so that the Parachute Value (as defined below) of all Payments, in the aggregate, equals the Safe Harbor Amount (as defined below). The Agreement Payments shall be so reduced only if the Accounting Firm determines that Executive would have a greater Net After-Tax Receipt (as defined below) of aggregate Payments if the Agreement Payments were so reduced. If the Accounting Firm determines that Executive would not have a greater Net After-Tax Receipt (as defined below) of aggregate Payments if the Agreement Payments were so reduced, Executive shall receive all Agreement Payments to which Executive is entitled hereunder.

(b) If the Accounting Firm determines that aggregate Agreement Payments should be reduced so that the Parachute Value of all Payments, in the aggregate, equals the Safe Harbor Amount, the Company shall promptly give Executive notice to that effect and a copy of the detailed calculation thereof. All determinations made by the Accounting Firm under this Section 8 shall be binding upon the Company and its Affiliates and Executive and shall be made as soon as reasonably practicable and in no event later than 15 days following the Date of Termination. For purposes of reducing the Agreement Payments so that the Parachute Value of all Payments, in the aggregate, equals the Safe Harbor Amount, only amounts payable under this Agreement (and no other Payments) shall be reduced. The reduction of the amounts payable hereunder, if applicable, shall be made by reducing the payments and benefits in the following order: (i) cash payments that may not be valued under Treas. Reg. § 1.280G¬1, Q&A-24(c) (“24(c)”), (ii) equity-based payments that may not be valued under 24(c), (iii) cash payments that may be valued under 24(c), (iv) equity-based payments that may be valued under 24(c) and (v) other types of benefits. With respect to each category of the foregoing, such reduction shall occur first with respect to amounts that are not “deferred compensation” within the meaning of Section 409A of the Code and next with respect to payments that are deferred compensation within the meaning of Section 409A of the Code, in each case, beginning with payments or benefits that are to be paid the farthest in time from the determination of the Accounting Firm. All reasonable fees and expenses of the Accounting Firm shall be borne solely by the Company.

 

16


(c) To the extent requested by Executive, the Company shall cooperate with Executive in good faith in valuing, and the Accounting Firm shall take into account the value of, services provided or to be provided by Executive (including Executive’s agreeing to refrain from performing services pursuant to a covenant not to compete or similar covenant, before, on or after the date of a change in ownership or control of the Company (within the meaning of Q&A-2(b) of the final regulations under Section 280G of the Code), such that payments in respect of such services may be considered reasonable compensation within the meaning of Q&A-9 and Q&A-40 to Q&A-44 of the final regulations under Section 280G of the Code and/or exempt from the definition of the term “parachute payment” within the meaning of Q&A-2(a) of the final regulations under Section 280G of the Code in accordance with Q&A-5(a) of the final regulations under Section 280G of the Code.

(d) The following terms shall have the following meanings for purposes of this Section 8:

(i) “Accounting Firm” shall mean a nationally recognized certified public accounting firm or other professional organization that is a certified public accounting firm recognized as an expert in determinations and calculations for purposes of Section 280G of the Code that is selected by the Company prior to a Change in Control for purposes of making the applicable determinations hereunder, which firm shall not, without Executive’s consent, be a firm serving as accountant or auditor for the Person effecting the Change in Control.

(ii) “Net After-Tax Receipt” shall mean the present value (as determined in accordance with Sections 280G(b)(2)(A)(ii) and 280G(d)(4) of the Code) of a Payment net of all taxes imposed on Executive with respect thereto under Sections 1 and 4999 of the Code and under applicable state and local laws, determined by applying the highest marginal rate under Section 1 of the Code and under state and local laws which applied to Executive’s taxable income for the immediately preceding taxable year, or such other rate(s) as the Accounting Firm reasonably determines to be likely to apply to Executive in the relevant tax year(s).

(iii) “Parachute Value” of a Payment shall mean the present value as of the date of the change of control for purposes of Section 280G of the Code of the portion of such Payment that constitutes a “parachute payment” under Section 280G(b)(2) of the Code, as determined by the Accounting Firm for purposes of determining whether and to what extent the excise tax under Section 4999 of the Code will apply to such Payment.

(iv) “Payment” shall mean any payment or distribution in the nature of compensation (within the meaning of Section 280G(b)(2) of the Code) to or for the benefit of Executive, whether paid or payable pursuant to the Agreement or otherwise.

(v) “Safe Harbor Amount” shall mean 2.99 times Executive’s “base amount,” within the meaning of Section 280G(b)(3) of the Code.

 

17


9. Successors. This Agreement is personal to Executive and without the prior written consent of the Company shall not be assignable by Executive otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by Executive’s legal representatives. This Agreement shall inure to the benefit of and be binding upon the Company and their respective successors and assigns. As used in this Agreement, “Parent” and “Company” shall mean Parent and the Company as hereinbefore defined and any successor to their respective businesses and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise.

10. Indemnification. Parent and the Company shall indemnify Executive and hold Executive harmless to the fullest extent permitted by the laws of the Republic of Ireland and the State of Michigan, respectively, against and in respect of any and all actions, suits, proceedings, claims, demands, judgments, costs, expenses, losses, and damages resulting from Executive’s good faith performance of Executive’s duties and obligations with the Company and its Affiliates. Parent and the Company shall cover Executive under directors’ and officers’ liability insurance both during and, while potential liability exists, after employment or non-employment service as a director or officer, as applicable, in the same amount and to the same extent as Parent and the Company cover their other officers and directors. These obligations shall survive the termination of Executive’s employment with the Company and its Affiliates. If any proceeding is brought or threatened against Executive in respect of which indemnity may be sought against the Company or its Affiliates pursuant to the foregoing, Executive shall notify the Company promptly in writing of the institution of such proceeding and the Company or its Affiliates shall assume the defense thereof and the employment of counsel and payment of all fees and expenses; provided, however, that if a conflict of interest exists between the Company or its applicable Affiliate and Executive such that it is not legally practicable for the Company or its applicable Affiliate to assume Executive’s defense, Executive shall be entitled to retain separate counsel reasonably acceptable to the Company or its applicable Affiliate and the Company or its applicable Affiliate shall assume payment of all reasonable fees and expenses of such counsel.

11. Miscellaneous.

(a) Governing Law and Dispute Resolution. This Agreement shall be governed by and construed in accordance with the laws of the State of Michigan, without reference to principles of conflict of laws. The parties irrevocably submit to the jurisdiction of any state or federal court sitting in or for Allegan or Kent Counties, Michigan with respect to any dispute arising out of or relating to this Agreement or the Release, and each party irrevocably agrees that all claims in respect of such dispute or proceeding shall be heard and determined in such courts. The parties hereby irrevocably waive, to the fullest extent permitted by law, any objection that they may now or hereafter have to the venue of any dispute arising out of or relating to this Agreement or the transactions contemplated hereby brought in such court or any defense of inconvenient forum for the maintenance of such dispute or proceeding. Each party agrees that a judgment in any such dispute may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. THE PARTIES HEREBY WAIVE A TRIAL BY JURY IN ANY ACTION, PROCEEDING, CLAIM OR COUNTER CLAIM BROUGHT OR ASSERTED BY EITHER OF THE PARTIES HERETO AGAINST THE OTHER ON ANY MATTERS WHATSOEVER ARISING OUT OF OR IN ANY WAY RELATED TO THIS AGREEMENT. Following a Change in Control, the Company (including any successor to the Company following a Change in Control) shall reimburse Executive for all reasonable legal fees and expenses incurred by Executive in seeking to obtain or enforce any right or benefit provided under this Agreement, provided that Executive substantially prevails on at least one material issue.

 

18


(b) Notices. All notices and other communications hereunder shall be in writing and shall be given by hand delivery to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows:

If to Executive: To the most recent address on file with the Company,

with a copy, which shall not constitute notice, to:

Barber Law, LLC

98 Washington Street

Morristown, NJ 07960

Attention: Kevin Barber

If to the Company:

Perrigo Management Company

515 Eastern Avenue

Allegan, Michigan 49010

Attention: General Counsel and

Chief Human Resources Officer

with a copy to Parent:

Perrigo Company plc

Treasury Building

Lower Grand Canal Street

Dublin 2 Ireland

Attention: General Counsel

or to such other address as either party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually received by the addressee.

(c) Acknowledgements; Representations. Prior to execution of this Agreement, Executive was advised by the Company of Executive’s right to seek independent advice from an attorney of Executive’s own selection regarding this Agreement. Executive acknowledges that he has entered into this Agreement knowingly and voluntarily and with full knowledge and understanding of the provisions of this Agreement after being given the opportunity to consult with counsel. Executive represents that, in entering into this Agreement, Executive is not relying on any statements or representations made by any of the directors, officers, employees or agents of the Company and its Affiliates that are not expressly set forth herein, and that Executive is relying only upon Executive’s own judgment and any advice provided by Executive’s attorney. Further, Executive represents and warrants that (i) Executive is not subject to any contract, arrangement, policy or understanding, or to any statute, governmental rule or regulation, that in any way limits Executive’s ability to enter into and fully perform Executive’s obligations under

 

19


this Agreement, (ii) Executive is not otherwise unable to enter into and fully perform Executive’s obligations under this Agreement and (iii) Executive has not engaged in any conduct, the occurrence and/or publicity of which, due to Executive’s affiliation with the Company or any of its Affiliates, is or could be harmful to, or otherwise reflect negatively on, the Company and/or any of its Affiliates. In the event of any breach of any of the representations, in the preceding sentence, the Company may terminate this Agreement and Executive’s employment without any liability owing to Executive.

(d) Cooperation. Executive agrees that upon the reasonable request of the Company or its Affiliates following Executive’s termination of employment, Executive shall use reasonable efforts to assist and cooperate with the Company or its Affiliates in connection with the defense or prosecution of any claim that may be made against or by the Company or its Affiliates, or in connection with any ongoing or future investigation or dispute or claim of any kind involving the Company or its Affiliates, including any proceedings before any arbitral, administrative, regulatory, judicial, legislative or other body or agency. Executive will be entitled to reimbursement for any reasonable out-of-pocket expenses (including travel expenses and attorneys’ fees) incurred in connection with providing such assistance and, in the event that Executive provides more than five hours of service collectively to the Company or its Affiliates in any calendar week at the Company’s or its Affiliates’ request pursuant to this Section 11(d), the Company shall compensate Executive at the rate of $480 per hour for such services in excess of five hours during such calendar week.

(e) Invalidity. If any term or provision of this Agreement or the application thereof to any person or circumstance shall to any extent be invalid or unenforceable, the remainder of this Agreement or the application of such term or provision to persons or circumstances other than those to which it is invalid or unenforceable shall not be affected thereby, and each term and provision of this Agreement shall be valid and be enforced to the fullest extent permitted by law.

(f) Survivability. The provisions of this Agreement that by their terms call for performance subsequent to the termination of either Executive’s employment or this Agreement (including the terms of Sections 5, 7 and 10) shall so survive such termination.

(g) Section Headings; Construction. The section headings used in this Agreement are included solely for convenience and shall not affect, or be used in connection with, the interpretation hereof. For purposes of this Agreement, the term “including” shall mean “including, without limitation.”

(h) Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument.

(i) Tax Withholding. The Company may withhold from any amounts payable under this Agreement such Federal, state, local or foreign taxes as shall be required to be withheld pursuant to any applicable law or regulation.

 

20


(j) Section 409A.

(i) General. It is intended that payments and benefits made or provided under this Agreement shall not result in penalty taxes or accelerated taxation pursuant to Section 409A of the Code. Any payments that qualify for the “short-term deferral” exception, the separation pay exception or another exception under Section 409A of the Code shall be paid under the applicable exception. For purposes of the limitations on nonqualified deferred compensation under Section 409A of the Code, each payment of compensation under this Agreement shall be treated as a separate payment of compensation. All payments to be made upon a termination of employment under this Agreement may only be made upon a “separation from service” under Section 409A of the Code to the extent necessary in order to avoid the imposition of penalty taxes on Executive pursuant to Section 409A of the Code. In no event may Executive, directly or indirectly, designate the calendar year of any payment under this Agreement, and to the extent required by Section 409A of the Code, any payment that may be paid in more than one taxable year (depending on the time that Executive executes the Release) shall be paid in the later taxable year.

(ii) Reimbursements and In-Kind Benefits. Notwithstanding anything to the contrary in this Agreement, all reimbursements and in-kind benefits provided under this Agreement that are subject to Section 409A of the Code shall be made in accordance with the requirements of Section 409A of the Code, including, where applicable, the requirement that (A) any reimbursement is for expenses incurred during Executive’s lifetime (or during a shorter period of time specified in this Agreement); (B) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during a calendar year may not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year; (C) the reimbursement of an eligible expense will be made no later than the last day of the calendar year following the year in which the expense is incurred; and (D) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.

(iii) Delay of Payments. Notwithstanding any other provision of this Agreement to the contrary, if Executive is considered a “specified employee” for purposes of Section 409A of the Code (as determined in accordance with the methodology established by the Company and its Affiliates as in effect on the Termination Date), any payment that constitutes nonqualified deferred compensation within the meaning of Section 409A of the Code that is otherwise due to Executive under this Agreement during the six-month period immediately following Executive’s separation from service (as determined in accordance with Section 409A of the Code) on account of Executive’s separation from service shall be accumulated and paid to Executive on the first business day of the seventh month following his separation from service (the “Delayed Payment Date”), to the extent necessary to prevent the imposition of tax penalties on Executive under Section 409A of the Code. If Executive dies during the postponement period, the amounts and entitlements delayed on account of Section 409A of the Code shall be paid to the personal representative of his estate on the first to occur of the Delayed Payment Date or 30 calendar days after the date of Executive’s death.

(k) Amendments. No provision of this Agreement shall be modified or amended except by an instrument in writing duly executed by the parties hereto. No custom, act, payment, favor or indulgence shall grant any additional right to Executive or be deemed a waiver by the Company

 

21


of any of Executive’s obligations hereunder or release Executive therefrom or impose any additional obligation upon the Company. No waiver by any party of any breach by the other party of any term or provision hereof shall be deemed to be an assent or waiver by any party to or of any succeeding breach of the same or any other term or provision. This Agreement is personal to and shall not be assignable by any party, but shall inure to the benefit of the parties hereto and their respective heirs, beneficiaries, successors and assigns.

(l) Entire Agreement. This Agreement constitutes the entire agreement of the parties hereto in respect of the terms and conditions of Executive’s employment with the Company and its Affiliates, including his severance entitlements, and, as of the Effective Date, supersedes and cancels in their entirety all prior understandings, agreements and commitments, whether written or oral, relating to the terms and conditions of employment between Executive, on the one hand, and the Company or its Affiliates, on the other hand.

[Signature page follows]

 

22


IN WITNESS WHEREOF, Executive has hereunto set Executive’s hand and the Company, pursuant to the authorization from its board of directors, has caused these presents to be executed in its name on its behalf, all as of the date first above written.

 

/s/ Patrick Lockwood-Taylor
Patrick Lockwood-Taylor
PERRIGO COMPANY
By:   /s/ Kyle L. Hanson
  Kyle L. Hanson

 

 

[Signature Page to Employment Agreement]


Exhibit A

GENERAL RELEASE OF CLAIMS

THIS GENERAL RELEASE OF CLAIMS (this “Release”) is executed by Patrick Lockwood-Taylor (“Executive”) as of the date set forth on the signature page hereto.

1. General Release and Waiver of Claims.

(a) Release. In consideration of the payments and benefits afforded under the employment agreement, dated as of ___________, by and between Perrigo Company, a Michigan corporation (the “Company”) and Executive (the “Employment Agreement”), and after consultation with counsel, Executive and each of Executive’s respective heirs, executors, administrators, representatives, agents, successors and assigns (collectively, the “Releasors”) hereby irrevocably and unconditionally release and forever discharge the Company and its subsidiaries and affiliates (including, but not limited to “Parent” (as such term is defined in the Employment Agreement) and each of their respective officers, employees, directors and agents (“Releasees”) from any and all claims, actions, causes of action, rights, judgments, obligations, damages, demands, accountings or liabilities of whatever kind or character (collectively, “Claims”) that the Releasors may have arising out of Executive’s employment relationship with and service as an employee, officer or director of the Company and its subsidiaries and affiliates, and the termination of any such relationship or service, in each case up to and including Executive’s date of termination. Executive acknowledges that the foregoing sentence includes Claims arising under Federal, state or local laws, statutes, orders or regulations that relate to the employment relationship or prohibiting employment discrimination, including Claims under Title VII of the Civil Rights Act of 1964; The Civil Rights Act of 1991; Sections 1981 through 1988 of Title 42 of the United States Code; the Employee Retirement Income Security Act of 1974; the Immigration Reform and Control Act; the Sarbanes-Oxley Act of 2002; the Americans with Disabilities Act of 1990; the Family and Medical Leave Act; the Equal Pay Act; the Fair Credit Reporting Act; Occupational Safety and Health Act; state equivalents of the foregoing statutes, including without limitation the Michigan Elliott Larsen Civil Rights Act, the Michigan Persons with Disabilities Civil Rights Act, and the Michigan Whistleblowers’ Protection Act; and any other federal, state or local civil, human rights, bias, whistleblower, discrimination, retaliation, compensation, employment, labor or other local, state or federal law, regulation or ordinance. Notwithstanding anything contained herein to the contrary, this Release specifically excludes and shall not affect: (i) the obligations of the Company or its affiliates set forth in the Employment Agreement and to be performed after the date hereof, including without limitation under in Sections 5, 8 and 10 thereof, or under any other benefit plan, agreement, arrangement or policy of the Company or its affiliates that is applicable to Executive and that, in each case, by its terms, contains obligations that are to be performed after the date hereof by the Company or its affiliates; (ii) any indemnification or similar rights Executive has as a current or former officer, director, employee or agent of the Company or its affiliates, including, without limitation, any and all rights thereto under applicable law, the bylaws or other governance documents or such entities, or any rights with respect to coverage under any directors’ and officers’ insurance policies and/or indemnification agreements; (iii) any Claim the Releasors may have as the holder or beneficial owners of securities of the Company or its affiliates or other rights relating to securities or equity awards in respect of the common stock of the Company or its affiliates; (iv) rights to accrued but unpaid salary, paid time off, vacation or other compensation due through the date of termination


of employment; (v) any unreimbursed business expenses; (vi) benefits or the right to seek benefits under applicable workers’ compensation and/or unemployment compensation statutes; and (vii) any Claims that may arise in the future from events or actions occurring after Executive’s date of termination of employment or that Executive may not by law release through an agreement such as this.

(b) Specific Release of ADEA Claims. In further consideration of the payments and benefits provided to Executive under the Employment Agreement, the Releasors hereby unconditionally release and forever discharge the Releasees from any and all Claims that the Releasors may have as of the date Executive signs this Release arising under the Federal Age Discrimination in Employment Act of 1967, as amended, and the applicable rules and regulations promulgated thereunder (“ADEA”). By signing this Release, Executive hereby acknowledges and confirms the following: (i) Executive was advised by the Company in connection with Executive’s termination of employment to consult with an attorney of Executive’s choice prior to signing this Release and to have such attorney explain to Executive the terms of this Release, including, without limitation, the terms relating to Executive’s release of claims arising under ADEA, and Executive has in fact consulted with an attorney; (ii) Executive was given a period of not fewer than [twenty-one (21)] [forty-five (45)] calendar days to consider the terms of this Release and to consult with an attorney of Executive’s choosing with respect thereto; and (iii) Executive knowingly and voluntarily accepts the terms of this Release. Executive also understands that Executive has seven (7) calendar days following the date on which Executive signs this Release within which to revoke the release contained in this Section 1(b), by providing the Company a written notice of Executive’s revocation of the release and waiver contained in this Section 1(b).

(c) No Assignment. Executive represents and warrants that Executive has not assigned any of the Claims being released under this Release.

2. Proceedings. Executive has not filed, and agrees not to initiate or cause to be initiated on Executive’s behalf, any complaint, charge, claim or proceeding against the Releasees with respect to any Claims released under Section 1(a) or (b) before any local, state or federal agency, court or other body (each, individually, a “Proceeding”), and agrees not to participate voluntarily in any Proceeding involving such Claims; provided, however, and subject to the immediately following sentence, nothing set forth here in intended to or shall interfere with Executive’s right to participate in a Proceeding with any appropriate federal, state, or local government agency enforcing discrimination laws, nor shall this Release prohibit Executive from cooperating with any such agency in its investigation. Executive waives any right Executive may have to benefit in any manner from any relief (whether monetary or otherwise) arising out of any Proceeding involving such Claims. Notwithstanding the foregoing, the term Proceeding shall not include any complaint, charge, claim or proceeding with respect to the obligations of the Company to Executive under the Employment Agreement or in respect of any other matter described in the proviso to Section 1(a), and Executive retains all of Executive’s rights in connection with the same.

3. Severability Clause. In the event any provision or part of this Release is found to be invalid or unenforceable, only that particular provision or part so found, and not the entire Release, will be inoperative.

 

2


4. No Admission. Nothing contained in this Release will be deemed or construed as an admission of wrongdoing or liability on the part of the Releasees.

5. Governing Law and Venue. All matters affecting this Release, including the validity thereof, are to be governed by, and interpreted and construed in accordance with, the laws of the State of Michigan applicable to contracts executed in and to be performed in that State.

6. Counterparts. This Release may be executed in counterparts and each counterpart will be deemed an original.

7. Notices. All notices, requests, demands or other communications under this Release shall be in writing and shall be deemed to have been duly given when delivered in person or deposited in the United States mail, postage prepaid, by registered or certified mail, return receipt requested, to the party to whom such notice is being given as follows:

As to Executive:

Executive’s last address on the books and records of the Company

As to the Company:

Perrigo Company

515 Eastern Avenue

Allegan, Michigan 49010

Attention: General Counsel

Chief Human Resources Officer

With a copy to Parent:

Perrigo Company plc

Treasury Building

Lower Grand Canal Street

Dublin 2 Ireland

Attention: General Counsel

Any party may change his, her or its address or the name of the person to whose attention the notice or other communication shall be directed from time to time by serving notice thereof upon the other party as provided herein.

[Signature page follows]

 

3


EXECUTIVE ACKNOWLEDGES THAT EXECUTIVE HAS READ THIS RELEASE AND THAT EXECUTIVE FULLY KNOWS, UNDERSTANDS AND APPRECIATES ITS CONTENTS, AND THAT EXECUTIVE HEREBY EXECUTES THE SAME AND MAKES THIS RELEASE AND THE RELEASE PROVIDED FOR HEREIN VOLUNTARILY AND OF EXECUTIVE’S OWN FREE WILL.

IN WITNESS WHEREOF, Executive has executed this Release on the date set forth below.

 

Patrick Lockwood-Taylor

Dated as of:

   

[Signature Page to General Release]

 

A-4

EX-10.2 3 d505583dex102.htm EX-10.2 EX-10.2

Exhibit 10.2

PERRIGO COMPANY PLC

RESTRICTED STOCK UNIT AWARD AGREEMENT

(PERFORMANCE-BASED)

(Under the Perrigo Company plc 2019 Long-Term Incentive Plan)

 

TO:

Participant Name

 

RE:

Notice of Restricted Stock Unit Award (Performance-Based)

This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”). This Award consists of performance-based restricted stock units. The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (“Appendix”) (collectively, the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.

SECTION 1

Restricted Stock Units – Performance-Based Vesting

1.1 Grant. As of the Grant Date, and subject to the terms and conditions of this Agreement and the Plan, the Company grants to you Number of Awards Granted performance-based restricted stock units (“PSUs”). The number of PSUs awarded in this Section 1.1 is referred to as the “Target Award.” The Target Award may be increased or decreased depending on the level of attainment of Performance Goals for designated Performance Measures as described in Section 1.2. Each PSU shall entitle you to one ordinary share of the Company, nominal value €0.001 per share (“Ordinary Share”) on the applicable PSU Vesting Date set forth in Section 1.2, provided the applicable Performance Goals for each Performance Measure are satisfied.

1.2 Vesting. Up to one-third (1/3) of the number of PSUs awarded in Section 1.1 shall be eligible to vest with respect to each Performance Period as of the applicable PSU Vesting Date. That number will be determined based on the level of attainment of annual Performance Measure(s) for such Performance Period, in accordance with the schedule determined by the Committee at the time the Performance Measures and applicable Performance Goals are established by the Committee.

The Committee shall establish annually one or more Performance Measures and the Performance Goals with respect to each Performance Measure that must be attained for Threshold, Target and Maximum performance for a Performance Period. The Performance Measure and Performance Goals for each Performance Period will be provided to you.

Following the end of each Performance Period, the Committee will determine the percentage of Target Award PSUs that will be payable for such Performance Period, based on the attainment of the Performance Goals for each Performance Measure(s) established by the Committee for that Performance Period. The percentage of the Target Award that will be payable under the schedule shall be adjusted, pro rata, to reflect the attained performance between Threshold and Target, and Target and Maximum.


At the end of each Performance Period, the percentage payout for the applicable Performance Period will determine the actual percentage of Target Award PSUs that will vest and be payable on the applicable PSU Vesting Date. In no event will the calculation of a positive payout percentage for any Performance Period be construed to guarantee that any PSUs will vest on the PSU Vesting Date.

Except as provided in Section 1.4, the PSUs eligible to vest with respect to a Performance Period will be permanently forfeited if your Termination Date occurs prior to the PSU Vesting Date for that Performance Period. If the annual performance payout for the Performance Period is less than the Threshold performance level established by the Committee, all PSUs that are eligible to vest for that Performance Period which have not previously been forfeited shall be forfeited as of the PSU Vesting Date for that Performance Period. If the annual performance payout for the Performance Period exceeds the Maximum performance level established by the Committee, in no event will the number of PSUs vesting for such Performance Period exceed 200% of the Target Award.

1.3 Definitions. The following terms shall have the following meanings under this Section 1.

(a) “Performance Goal” means the level of performance that must be attained with respect to a Performance Measure for a Performance Period for Minimum, Target and Maximum payout.

(b) “Performance Measure” for any Performance Period means one or more financial measures, as determined by the Committee. The Committee shall provide how the Performance Measure will be adjusted, if at all, as a result of extraordinary events or circumstances, as determined by the Committee, or to exclude the effects of extraordinary, unusual, or non-recurring items; changes in applicable laws, regulations, or accounting principles; currency fluctuations; discontinued operations; non-cash items, such as amortization, depreciation, or reserves; asset impairment; or any recapitalization, restructuring, reorganization, merger, acquisition, divestiture, consolidation, spin-off, split-up, combination, liquidation, dissolution, sale of assets, or other similar corporation transaction.

(c) “Performance Period” means each of (i) the First Performance Period, which begins on the first day of the fiscal year of the Company in which the Grant Date occurs and ends on the last day of such fiscal year, (ii) the Second Performance Period, which begins on the first day of the fiscal year immediately following the end of the First Performance Period and ends on the last day of such fiscal year, and (iii) the Third Performance Period, which begins on the first day of the fiscal year immediately following the end of the Second Performance Period and ends on the last day of such fiscal year.

(d) “PSU Vesting Date” means the last day of each Performance Period.

 

2


(e) “Separation for Good Reason” means your voluntary resignation from the Company and the existence of one or more of the following conditions that arose without your consent: (i) a material change in the geographic location at which you are required to perform services, such that your commute between home and your primary job site increases by more than 30 miles, or (ii) a material diminution in your authority, duties or responsibilities or a material diminution in your base compensation or incentive compensation opportunities; provided, however, that a voluntary resignation from the Company shall not be considered a Separation for Good Reason unless you provide the Company with notice, in writing, of your voluntary resignation and the existence of the condition(s) giving rise to the separation within 90 days of its initial existence. The Company will then have 30 days to remedy the condition, in which case you will not be deemed to have incurred a Separation for Good Reason. In the event the Company fails to cure the condition within the 30 day period, your Termination Date shall occur on the 31st day following the Company’s receipt of such written notice.

(f) “Termination without Cause” means the involuntary termination of your employment or contractual relationship by the Company without Cause, including, but not limited to, (i) a termination effective when you exhaust a leave of absence during, or at the end of, a notice period under the Worker Adjustment and Retraining Notification Act (“WARN”), and (ii) a situation where you are on an approved leave of absence during which your position is protected under applicable law (e.g., a leave under the Family Medical Leave Act), you return from such leave, and you cannot be placed in employment or other form of contractual relationship with the Company.

1.4 Special Vesting Rules. Notwithstanding Section 1.2 above, if your Termination Date occurs by reason of a Termination without Cause or a Separation for Good Reason on or after a Change in Control (as defined in the Plan and as such definition may be amended hereafter) and prior to the two (2) year anniversary of the Change in Control, all of the PSUs awarded under Section 1.1 that have not previously been forfeited shall become fully vested as if Target performance had been obtained for the Performance Period effective as of your Termination Date. If your Termination Date occurs because of death, Disability, or Retirement, the PSUs shall vest or be forfeited as of the PSU Vesting Dates set forth in Section 1.2, based on the attainment of the performance goals. If your Termination Date occurs in the 24-month period preceding the PSU Vesting Date for the Third Performance Period because of an Involuntary Termination for Economic Reasons, all of the PSUs awarded hereunder shall vest or be forfeited as of the dates set forth in Section 1.2, depending on the attainment of Performance Goals; provided, however, that if your Termination Date occurs for a reason that is both described in this sentence and in the first sentence of this Section 1.4, the special vesting rules described in the first sentence of this Section 1.4 shall apply in lieu of the vesting rules described in this sentence. If your Termination Date occurs by reason of a Termination without Cause (including, for the avoidance of doubt, a Termination Date occurring by reason of the Company’s non-renewal of your employment agreement) or a Separation for Good Reason, all of the PSUs awarded hereunder shall vest or be forfeited as of the PSU Vesting Date set forth in Section 1.2, depending on the attainment of Performance Goals; provided, however, that if your Termination Date occurs for a reason that is both described in this sentence and in the first sentence of this Section 1.4, the special vesting rules described in the first sentence of this Section 1.4 shall apply in lieu of the vesting rules described in this sentence.

 

3


1.5 Settlement of PSUs. As soon as practicable following the date of the Committee’s first regularly scheduled meeting following the last day of the Performance Period at which the Committee certifies the payout for the Performance Period (or, if earlier, the date on which the PSUs become vested pursuant to the special vesting rules described in Section 1.4), the Company shall transfer to you one Ordinary Share for each PSU, if any, that becomes vested pursuant to Section 1.2 or 1.4 of this Agreement (the date of any such transfer shall be the “settlement date” for purposes of this Agreement); provided, however, the Company in its discretion may settle PSUs in cash, based on the fair market value of the shares on the vesting date. No fractional shares shall be transferred. Any fractional share shall be rounded to the nearest whole share. The income attributable to the vesting of PSUs and the amount of any required tax withholding will be determined based on the value of the shares on the settlement date. PSUs are not eligible for dividend equivalents.

SECTION 2

General Terms and Conditions

2.1 Nontransferability. The Award under this Agreement shall not be transferable other than by will or by the laws of descent and distribution.

2.2 No Rights as a Stockholder. You shall not have any rights as a stockholder with respect to any Ordinary Shares subject to the PSU awarded under this Agreement prior to the date of issuance to you of a certificate or certificates for such shares.

2.3 Cause Termination. If your Termination Date occurs for reasons of Cause, all of your rights under this Agreement, whether or not vested, shall terminate immediately.

2.4 Award Subject to Plan. The granting of the Award under this Agreement is being made pursuant to the Plan and the Award shall be payable only in accordance with the applicable terms of the Plan. The Plan contains certain definitions, restrictions, limitations and other terms and conditions all of which shall be applicable to this Agreement. ALL THE PROVISIONS OF THE PLAN ARE INCORPORATED HEREIN BY REFERENCE AND ARE MADE A PART OF THIS AGREEMENT IN THE SAME MANNER AS IF EACH AND EVERY SUCH PROVISION WERE FULLY WRITTEN INTO THIS AGREEMENT. Should the Plan become void or unenforceable by operation of law or judicial decision, this Agreement shall have no force or effect. Nothing set forth in this Agreement is intended, nor shall any of its provisions be construed, to limit or exclude any definition, restriction, limitation or other term or condition of the Plan as is relevant to this Agreement and as may be specifically applied to it by the Committee. In the event of a conflict in the provisions of this Agreement and the Plan, as a rule of construction the terms of the Plan shall be deemed superior and apply.

2.5 Adjustments in Event of Change in Ordinary Shares. In the event of a stock split, stock dividend, recapitalization, reclassification or combination of shares, merger, sale of assets or similar event, the number and kind of shares subject to Award under this Agreement will be appropriately adjusted in an equitable manner to prevent dilution or enlargement of the rights granted to or available for you.

2.6 Acknowledgment. The Company and you agree that the PSUs are granted under and governed by the Notice of Grant, this Agreement (including the Appendix, if applicable) and by the provisions of the Plan (incorporated herein by reference). You: (i) acknowledge receipt of a copy of each of the foregoing documents, (ii) represent that you have carefully read and are familiar with their provisions, and (iii) hereby accept the PSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice of Grant.

 

4


2.7 Taxes and Withholding.

(a) Withholding (Only Applicable to Individuals Subject to U.S. Tax Laws). This Award is subject to the withholding of all applicable taxes. The Company may withhold, or permit you to remit to the Company, any Federal, state or local taxes applicable to the grant, vesting or other event giving rise to tax liability with respect to this Award. If you have not remitted the full amount of applicable withholding taxes to the Company by the date the Company is required to pay such withholding to the appropriate taxing authority (or such earlier date that the Company may specify to assist it in timely meeting its withholding obligations), the Company shall have the unilateral right to withhold Ordinary Shares relating to this Award in the amount it determines is sufficient to satisfy the tax withholding required by law. State taxes will be withheld at the appropriate rate set by the state in which you are employed or were last employed by the Company. In no event may the number of shares withheld exceed the number necessary to satisfy the maximum Federal, state and local income and employment tax withholding requirements. You may elect to surrender previously acquired Ordinary Shares or to have the Company withhold Ordinary Shares relating to this Award in an amount sufficient to satisfy all or a portion of the tax withholding required by law.

(b) Responsibility for Taxes (Only Applicable to Individuals Subject to Tax Laws Outside the U.S.). Regardless of any action the Company or, if different, the Affiliate employing or retaining you takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to your participation in the Plan and legally applicable to you (“Tax-Related Items”), you acknowledge that the ultimate liability for all Tax-Related Items is and remains your responsibility and may exceed the amount actually withheld by the Company or the Affiliate employing or retaining you. You further acknowledge that the Company and/or the Affiliate employing or retaining you (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PSUs, including, but not limited to, the grant, vesting or settlement of the PSUs, the subsequent sale of Ordinary Shares acquired pursuant to such settlement and the receipt of any dividends; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the PSUs to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result. Further, if you have become subject to tax in more than one jurisdiction between the PSU Grant Date and the date of any relevant taxable event, as applicable, you acknowledge that the Company and/or the Affiliate employing or retaining you (or formerly employing or retaining you, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

(1) Prior to any relevant taxable or tax withholding event, as applicable, you will pay or make adequate arrangements satisfactory to the Company and/or the Affiliate employing or retaining you to satisfy all Tax-Related Items. In this regard, you authorize the Company and/or the Affiliate employing or retaining you, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following:

 

5


(A) withholding from your wages or other cash compensation paid to you by the Company and/or the Affiliate employing or retaining you; or

(B) withholding from proceeds of the sale of Ordinary Shares acquired upon settlement of the PSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization); or

(C) withholding in Ordinary Shares to be issued upon settlement of the PSUs.

(2) To avoid negative accounting treatment, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in Ordinary Shares, for tax purposes, you are deemed to have been issued the full number of Ordinary Shares subject to the vested PSUs, notwithstanding that a number of the Ordinary Shares are held back solely for the purpose of paying the Tax-Related Items.

(3) Finally, you shall pay to the Company or the Affiliate employing or retaining you any amount of Tax-Related Items that the Company or the Affiliate employing or retaining you may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the Ordinary Shares or the proceeds of the sale of Ordinary Shares, if you fail to comply with your obligations in connection with the Tax-Related Items.

2.8 Compliance with Applicable Law. The issuance of Ordinary Shares will be subject to and conditioned upon compliance by the Company and you, including any written representations, warranties and agreements as the Administrator may request of you for compliance with all (i) applicable U.S. state and federal laws and regulations, (ii) applicable laws of the country where you reside pertaining to the issuance or sale of Ordinary Shares, and (iii) applicable requirements of any stock exchange or automated quotation system on which the Company’s Ordinary Shares may be listed or quoted at the time of such issuance or transfer. Notwithstanding any other provision of this Agreement, the Company shall have no obligation to issue any Ordinary Shares under this Agreement if such issuance would violate any applicable law or any applicable regulation or requirement of any securities exchange or similar entity.

2.9 Short Term Deferral (Only Applicable to Individuals Subject to U.S. Federal Tax Laws). PSUs payable under this Agreement are intended to be exempt from Code Section 409A under the exemption for short-term deferrals. Accordingly, PSUs will be settled no later than the 15th day of the third month following the later of (i) the end of the Employee’s taxable year in which the vesting date occurs, or (ii) the end of the fiscal year of the Company in which the vesting date occurs.

 

6


2.10 Data Privacy.

(a) U.S. Data Privacy Rules (Only Applicable if this Award is Subject to U.S. Data Privacy Laws). By entering into this Agreement and accepting this Award, you (a) explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of any of your personal data that is necessary to facilitate the implementation, administration and management of the Award and the Plan, (b) understand that the Company may, for the purpose of implementing, administering and managing the Plan, hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, and details of all awards or entitlements to Shares granted to you under the Plan or otherwise (“Personal Data”), (c) understand that Personal Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including any broker with whom the Shares issued upon vesting of the Award may be deposited, and that these recipients may be located in your country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than your country, (d) waive any data privacy rights you may have with respect to the data, and (e) authorize the Company, its Affiliates and its agents, to store and transmit such information in electronic form.

(b) Non-U.S. Data Privacy Rules (Only Applicable if this Award is Subject to Data Privacy Laws Outside of the U.S.)

(1) By entering into this Agreement and accepting this Award, you hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Agreement and any other PSU grant materials by and among, as applicable, the Affiliate employing or retaining you, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.

(2) You understand that the Company and the Affiliate employing or retaining you may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Ordinary Shares or directorships held in the Company, details of all PSUs or any other entitlement to Ordinary Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the exclusive purpose of implementing, administering and managing the Plan (“Data”).

(3) You understand that Data will be transferred to legal counsel or a broker or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. You understand that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than your country of residence. You understand that if you reside outside the United States, you may request a list with the names and addresses of any potential recipients of the Data by contacting your local or Company human resources representative. You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan. You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan. You understand that if you reside outside the United States, you may, at any time, view Data, request additional information about the storage and processing of Data,

 

7


require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local or Company human resources representative. You understand, however, that refusing or withdrawing your consent may affect your ability to participate in the Plan. For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local or Company human resources representative.

2.11 Successors and Assigns. This Agreement shall be binding upon any or all successors and assigns of the Company.

2.12 Applicable Law. This Agreement shall be governed by and construed and enforced in accordance with the applicable Code provisions to the maximum extent possible and otherwise by the laws of the State of Michigan without regard to principals of conflict of laws, provided that if you are a foreign national or employed outside the United States, this Agreement shall be governed by and construed and enforced in accordance with applicable foreign law to the extent that such law differs from the Code and Michigan law. Any proceeding related to or arising out of this Agreement shall be commenced, prosecuted or continued in the Circuit Court in Kent County, Michigan located in Grand Rapids, Michigan or in the United Stated District Court for the Western District of Michigan, and in any appellate court thereof.

2.13 Forfeiture of PSUs. If the Company, as a result of misconduct, is required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws, then (a) if your incentive or equity-based compensation is subject to automatic forfeiture due to such misconduct and restatement under Section 304 of the Sarbanes-Oxley Act of 2002, or (b) the Committee determines you either knowingly engaged in or failed to prevent the misconduct, or your actions or inactions with respect to the misconduct and restatement constituted gross negligence, you shall (i) be required to reimburse the Company the amount of any payment relating to any PSUs earned or accrued during the twelve month period following the first public issuance or filing with the SEC (whichever first occurred) of the financial document embodying such financial reporting requirement, and (ii) all outstanding PSUs that have not yet been settled shall be immediately forfeited. In addition, Ordinary Shares acquired under this Agreement, and any gains or profits on the sale of such Ordinary Shares, shall be subject to any “clawback” or recoupment policy later adopted by the Company.

2.14 Special Rules for Non-U.S. Grantees (Only Applicable if You Reside Outside of the U.S.)

(a) Nature of Grant. In accepting the grant, you acknowledge, understand and agree that:

(1) the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, except as otherwise provided in the Plan.

(2) the grant of the PSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of PSUs, or benefits in lieu of the PSUs, even if PSUs have been granted repeatedly in the past;

 

8


(3) all decisions with respect to future PSU grants, if any, will be at the sole discretion of the Company;

(4) you are voluntarily participating in the Plan;

(5) the PSUs and the Ordinary Shares subject to the PSUs are an extraordinary item and which is outside the scope of your employment or service contract, if any;

(6) the PSUs and the Ordinary Shares subject to the PSUs are not intended to replace any pension rights or compensation;

(7) the PSUs and the Ordinary Shares subject to the PSUs are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the Affiliate employing or retaining you or any other Affiliate;

(8) the grant and your participation in the Plan will not be interpreted to form an employment or service contract with the Company or any Affiliate;

(9) the future value of the underlying Ordinary Shares is unknown, indeterminable and cannot be predicted with certainty;

(10) no claim or entitlement to compensation or damages shall arise from forfeiture of the PSUs resulting from your Termination Date (for any reason whatsoever, whether or not later found to be invalid and whether or not in breach of employment laws in the jurisdiction where you are employed or rendering services, or the terms of your employment agreement, if any), and in consideration of the grant of the PSUs to which you are otherwise not entitled, you irrevocably agree never to institute any claim against the Company or the Affiliate employing or retaining you, waive your ability, if any, to bring any such claim, and release the Company and the Affiliate employing or retaining you from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, you shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claim; and

(11) you acknowledge and agree that neither the Company, the Affiliate employing or retaining you nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between the currency of the country in which you reside and the United States Dollar that may affect the value of the PSUs or of any amounts due to you pursuant to the settlement of the PSUs or the subsequent sale of any Ordinary Shares acquired upon settlement.

(b) Appendix. Notwithstanding any provisions in this Agreement, the PSU grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement. Moreover, if you relocate to one of the countries included in the Appendix, the special terms and conditions for such country will apply to you, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply

 

9


with laws of the country where you reside or to facilitate the administration of the Plan. If you relocate to the United States, the special terms and conditions in the Appendix will apply, or cease to apply, to you, to the extent the Company determines that the application or otherwise of such provisions is necessary or advisable in order to facilitate the administration of the Plan. The Appendix constitutes part of this Agreement.

(c) Imposition of Other Requirements. The Company reserves the right to impose other requirements on your participation in the Plan, on the PSUs and on any Ordinary Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

2.15 Noncompetition and Nonsolicitation.

(a) Noncompetition. During your employment with the Company and its Affiliates and for a twelve (12) month period following your Termination Date (the “Restricted Period”), you shall not (i) directly or indirectly, without the prior written consent of the Company, engage in or invest as an owner, partner, stockholder, licensor, director, officer, agent or consultant for any Person that conducts a business that is in competition with a business conducted by the Company or any of its Affiliates anywhere in the world; or (ii) accept employment or an engagement for the provision of services in any capacity, including as an employee, director, consultant or advisor, directly or indirectly, with any Person that conducts a business that is in competition with a business conducted by the Company or any of its Affiliates anywhere in the world except where prohibited by local law. For purposes hereof, conducting a business that is in competition with a business conducted by the Company or any of its Affiliates shall include the sale, manufacture, distribution or research and development of any product or service that is similar to a product or service sold, distributed, marketed or being researched or developed (including through a joint venture or investment in another entity) by the Company or any of its Affiliates, including store brand and value brand OTC drug or nutritional products, extended topical generic prescription pharmaceutical products, infant nutrition products, oral care products, and any other product or products that the Company or an Affiliate is marketing or actively planning to market during your employment with the Company and during the one-year period following your Termination Date. If there is a completed sale, transfer or other disposition of the Perrigo Prescription Pharmaceutical business during the Restricted Period, this Section 2.15(a) will not apply to the Perrigo Prescription Pharmaceutical business. Notwithstanding the foregoing, nothing in this provision shall prevent you from passively owning two percent (2%) or less of the outstanding securities of any class of any company listed on a national securities exchange or quoted on an automated quotation system. You may make a written request in writing to the CHRO of the Company for an exception to this Section 2.15(a) and such exception will not be unreasonably withheld.

 

10


(b) Nonsolicitation of Service Providers. During your employment with the Company and its Affiliates and for the duration of the Restricted Period, you shall not, directly or indirectly, without the prior written consent of the Company, (i) actively solicit, recruit or hire any Person who is at such time, or who at any time during the 12-month period prior to such solicitation or hiring had been, an employee or consultant of the Company or any of its Affiliates, (ii) solicit or encourage any employee of the Company or any of its Affiliates to leave the employment of the Company or any of its Affiliates or (iii) interfere with the relationship of the Company or any of its Affiliates with any Person or entity who or that is employed by or otherwise engaged to perform services for the Company or any of its Affiliates except where prohibited by local law.

(c) Nonsolicitation of Clients. During your employment with the Company and its Affiliates and for the duration of the Restricted Period, you shall not, directly or indirectly, alone or in association with any other Person, without the prior written consent of the Company, (i) induce or attempt to induce any client, customer (whether former or current), supplier, licensee, franchisee, joint venture partner or other business relation of the Company or any of its Affiliates (collectively, “Clients”) to cease doing business with the Company or any such Affiliate, (ii) divert all or any portion of a Client’s business with the Company to any competitor of the Company or any such Affiliate, or (iii) in any way interfere with the relationship between any Client, on the one hand, and the Company or any such Affiliate, on the other hand except where prohibited by local law.

(d) Remedies and Injunctive Relief. You acknowledge that a violation by you of any of the covenants contained in this Section 2.15 would cause irreparable damage to the Company and its Affiliates in an amount that would be material but not readily ascertainable, and that any remedy at law (including the payment of damages) would be inadequate. Accordingly, you agree that, notwithstanding any provision of this Agreement to the contrary, in addition to any other damages it is able to show, the Company and its Affiliates shall be entitled (without the necessity of showing economic loss or other actual damage) to injunctive relief (including temporary restraining orders, preliminary injunctions and permanent injunctions), without posting a bond, in any court of competent jurisdiction for any actual or threatened breach of any of the covenants set forth in this Section 2.15 in addition to any other legal or equitable remedies it may have. In addition, in the event of your Willful Restrictive Covenant Breach (as defined in this Section 2.15), (i) all of your rights under this Agreement, whether or not vested, shall terminate immediately, and (ii) any Shares, cash or other property paid or delivered to you pursuant to this Agreement shall be forfeited and you shall be required to repay such Shares, cash or other property to the Company, no later than thirty (30) calendar days after the Company makes demand to you for repayment. For purposes of this Agreement, “Willful Restrictive Covenant Breach” means your material breach of any of the covenants set forth in this Section 2.15 which you knew, or with due inquiry, should have known, would constitute such a material breach. The preceding sentences of this Section 2.15 shall not be construed as a waiver of the rights that the Company and its Affiliates may have for damages under this Agreement or otherwise, and all such rights shall be unrestricted. The Restricted Period shall be tolled during (and shall be deemed automatically extended by) any period during which you are in violation of the provisions of Section 2.15(a), (b) or (c), as applicable. In the event that a court of competent jurisdiction determines that any provision of this Section 2.15 is invalid or more restrictive than permitted under the governing law of such jurisdiction, then, only as to enforcement of this Section 2.15 within the jurisdiction of such court, such provision shall be interpreted and enforced as if it provided for the maximum restriction permitted under such governing law.

 

11


(e) Acknowledgments.

(1) You acknowledge that the Company and its Affiliates have expended and will continue to expend substantial amounts of time, money and effort to develop business strategies, employee, customer and other relationships and goodwill to build an effective organization. You acknowledge that the Company and its Affiliates have a legitimate business interest in and right to protect its goodwill and employee, customer and other relationships, and that the Company and its Affiliates could be seriously damaged by the loss or deterioration of its employee, customer and other relationships. You further acknowledge that the Company and its Affiliates are entitled to protect and preserve the going concern value of the Company and its Affiliates to the extent permitted by law.

(2) In light of the foregoing acknowledgments, you agree that the covenants contained in this Agreement are reasonable and properly required for the adequate protection of the businesses and goodwill of the Company and its Affiliates. You further acknowledge that, although your compliance with the covenants contained in this Agreement may prevent you from earning a livelihood in a business similar to the business of the Company and its Affiliates, your experience and capabilities are such that you have other opportunities to earn a livelihood and adequate means of support for you and your dependents.

(3) In light of the acknowledgements contained in this Section 2.15, you agree not to challenge or contest the reasonableness, validity or enforceability of any limitations on, and obligations of, you contained in this Section 2.15.

****

We look forward to your continuing contribution to the growth of the Company. Please acknowledge your receipt of the Plan and this Award.

 

Very truly yours,
/s/ Orlando Ashford
Orlando Ashford
Chairman of the Board

 

12

EX-10.3 4 d505583dex103.htm EX-10.3 EX-10.3

Exhibit 10.3

PERRIGO COMPANY PLC

RESTRICTED STOCK UNIT AWARD AGREEMENT

(SERVICE-BASED)

(Under the Perrigo Company plc 2019 Long-Term Incentive Plan)

 

TO:

Participant Name

 

RE:

Notice of Restricted Stock Unit Award (Service-Based)

This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award under the Perrigo Company plc 2019 Long-Term Incentive Plan (the “Plan”), effective as of Grant Date (the “Grant Date”). This Award consists of service-based restricted stock units. The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (“Appendix”) (collectively, the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.

SECTION 1

Restricted Stock Units – Service-Based Vesting

1.1 Grant. As of the Grant Date, and subject to the terms and conditions of this Agreement and the Plan, the Company grants you Number of Awards Granted (“Restricted Stock Units” or “RSUs”). Each RSU shall entitle you to one ordinary share of the Company, nominal value €0.001 per share (“Ordinary Share”) on the applicable RSU Vesting Date, provided the vesting conditions described in Section 1.2 are satisfied.

1.2 Vesting. Except as provided in Section 1.3, the RSUs awarded in Section 1.1 shall vest as follows following the Grant Date (“RSU Vesting Date(s)”): Vesting Schedule (Dates & Quantities); provided, however, that you continue in the service of the Company from the Grant Date through the applicable RSU Vesting Date.

Except as provided in Section 1.3, if your Termination Date occurs prior to the RSU Vesting Date, any RSUs awarded under Section 1.1 that have not previously vested as of such Termination Date shall be permanently forfeited on your Termination Date.

1.3 Special Vesting Rules. Notwithstanding Section 1.2 above:

(a) If your Termination Date occurs by reason of death, Disability or Retirement with the Company’s consent, any RSUs awarded under Section 1.1 that have not vested prior to such Termination Date shall become fully vested.

(b) If your Termination Date occurs by reason of an Involuntary Termination for Economic Reasons, any RSUs awarded under Section 1.1 that would otherwise be scheduled to vest under Section 1.2 in the 24-month period following such Termination Date shall continue to vest during such 24-month period according to the vesting schedule in effect prior to such Termination Date; provided, however, that if your Termination Date occurs for a reason that is


both described in this subsection (b) and in subsection (d) below, the special vesting rules described in subsection (d) shall apply in lieu of the vesting rules described in this subsection (b). Any RSUs that are not scheduled to vest during such 24-month period will be permanently forfeited on the Termination Date.

(c) If your Termination Date occurs by reason of a Termination without Cause (including, for the avoidance of doubt, a Termination Date occurring by reason of the Company’s non-renewal of your employment agreement) or a Separation for Good Reason, all RSUs awarded under Section 1.1 that have not vested or been forfeited prior to such Termination Date shall continue to vest according to the vesting schedule in effect prior to such Termination Date; provided, however, that if your Termination Date occurs for a reason that is both described in this subsection (c) and in subsection (d) below, the special vesting rules described in subsection (d) shall apply in lieu of the vesting rules described in this subsection (c).

(d) If your Termination Date occurs by reason of a Termination without Cause or a Separation for Good Reason on or after a Change in Control (as defined in the Plan and as such definition may be amended hereafter) and prior to the two (2) year anniversary of the Change in Control, all RSUs awarded under Section 1.1 that have not vested or been forfeited prior to such Termination Date shall become fully vested.

(e) As used in this Section 1.3, the following terms shall have the meanings set forth below:

(1) “Separation for Good Reason” means your voluntary resignation from the Company and the existence of one or more of the following conditions that arose without your consent: (i) a material change in the geographic location at which you are required to perform services, such that your commute between home and your primary job site increases by more than 30 miles, or (ii) a material diminution in your authority, duties or responsibilities or a material diminution in your base compensation or incentive compensation opportunities; provided, however, that a voluntary resignation from the Company shall not be considered a Separation for Good Reason unless you provide the Company with notice, in writing, of your voluntary resignation and the existence of the condition(s) giving rise to the separation within 90 days of its initial existence. The Company will then have 30 days to remedy the condition, in which case you will not be deemed to have incurred a Separation for Good Reason. In the event the Company fails to cure the condition within the 30-day period, your Termination Date shall occur on the 31st day following the Company’s receipt of such written notice.

(2) “Termination without Cause” means the involuntary termination of your employment or contractual relationship by the Company without Cause, including, but not limited to, (i) a termination effective when you exhaust a leave of absence during, or at the end of, a notice period under the Worker Adjustment and Retraining Notification Act (“WARN”), and (ii) a situation where you are on an approved leave of absence during which your position is protected under applicable law (e.g., a leave under the Family Medical Leave Act), you return from such leave, and you cannot be placed in employment or other form of contractual relationship with the Company.

 

2


1.4 Settlement of RSUs. As soon as practicable after the RSU Vesting Date, the Company shall transfer to you one Ordinary Share for each RSUs becoming vested on such date (the date of any such transfer shall be the “settlement date” for purposes of this Agreement); provided, however, the Company may withhold shares otherwise transferable to you to the extent necessary to satisfy withholding taxes due by reason of the vesting of the RSUs, in accordance with Section 2.6. You shall have no rights as a stockholder with respect to the RSUs awarded hereunder prior to the date of issuance to you of a certificate or certificates for such shares. Notwithstanding the foregoing, the Committee, in its sole discretion, may elect to settle RSUs in cash based on the fair market value of the Ordinary Shares on the RSU Vesting Date.

1.5 Dividend Equivalents. The RSUs awarded under Section 1.1 shall be eligible to receive dividend equivalents in accordance with the following:

(a) An “Account” will be established in your name. Such Account shall be for recordkeeping purposes only, and no assets or other amounts shall be set aside from the Company’s general assets with respect to such Account.

(b) On each date that a cash dividend is paid with respect to Ordinary Shares, the Company shall credit your Account with the dollar amount of dividends you would have received if each RSU held by you on the record date for such dividend payment had been an Ordinary Share. No interest or other earnings shall accrue on such Account.

(c) As of each RSU Vesting Date, you shall receive a payment equal to the amount of dividends that would have been paid on the RSUs vesting on such date had they been Ordinary Shares during the period beginning on the Grant Date and ending on the RSU Vesting Date, and the Account shall be debited appropriately. If you forfeit RSUs, any amounts in the Account attributable to such RSUs shall also be forfeited.

(d) If dividends are paid in the form of Ordinary Shares rather than cash, then you will be credited with one additional RSU for each Ordinary Share that would have been received as a dividend had your outstanding RSUs been Ordinary Shares. Such additional RSUs shall vest or be forfeited at the same time as the RSU to which they relate.

SECTION 2

General Terms and Conditions

2.1 Nontransferability. The Award under this Agreement shall not be transferable other than by will or by the laws of descent and distribution.

2.2 No Rights as a Stockholder. You shall not have any rights as a stockholder with respect to any Ordinary Shares subject to the RSU awarded under this Agreement prior to the date of issuance to you of a certificate or certificates for such shares.

2.3 Cause Termination. If your Termination Date occurs for reasons of Cause, all of your rights under this Agreement, whether or not vested, shall terminate immediately.

 

3


2.4 Award Subject to Plan. The granting of the Award under this Agreement is being made pursuant to the Plan and the Award shall be payable only in accordance with the applicable terms of the Plan. The Plan contains certain definitions, restrictions, limitations and other terms and conditions all of which shall be applicable to this Agreement. ALL THE PROVISIONS OF THE PLAN ARE INCORPORATED HEREIN BY REFERENCE AND ARE MADE A PART OF THIS AGREEMENT IN THE SAME MANNER AS IF EACH AND EVERY SUCH PROVISION WERE FULLY WRITTEN INTO THIS AGREEMENT. Should the Plan become void or unenforceable by operation of law or judicial decision, this Agreement shall have no force or effect. Nothing set forth in this Agreement is intended, nor shall any of its provisions be construed, to limit or exclude any definition, restriction, limitation or other term or condition of the Plan as is relevant to this Agreement and as may be specifically applied to it by the Committee. In the event of a conflict in the provisions of this Agreement and the Plan, as a rule of construction the terms of the Plan shall be deemed superior and apply.

2.5 Adjustments in Event of Change in Ordinary Shares. In the event of a stock split, stock dividend, recapitalization, reclassification or combination of shares, merger, sale of assets or similar event, the number and kind of shares subject to Award under this Agreement will be appropriately adjusted in an equitable manner to prevent dilution or enlargement of the rights granted to or available for you.

2.6 Acknowledgement. The Company and you agree that the RSUs are granted under and governed by the Notice of Grant, this Agreement (including the Appendix, if applicable) and by the provisions of the Plan (incorporated herein by reference). You: (i) acknowledge receipt of a copy of each of the foregoing documents, (ii) represent that you have carefully read and are familiar with their provisions, and (iii) hereby accept the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice of Grant.

2.7 Taxes and Withholding.

(a) Withholding (Only Applicable to Individuals Subject to U.S. Tax Laws). This Award is subject to the withholding of all applicable taxes. The Company may withhold, or permit you to remit to the Company, any Federal, state or local taxes applicable to the grant, vesting or other event giving rise to tax liability with respect to this Award. If you have not remitted the full amount of applicable withholding taxes to the Company by the date the Company is required to pay such withholding to the appropriate taxing authority (or such earlier date that the Company may specify to assist it in timely meeting its withholding obligations), the Company shall have the unilateral right to withhold Ordinary Shares relating to this Award in the amount it determines is sufficient to satisfy the tax withholding required by law. State taxes will be withheld at the appropriate rate set by the state in which you are employed or were last employed by the Company. In no event may the number of shares withheld exceed the number necessary to satisfy the maximum Federal, state and local income and employment tax withholding requirements. You may elect to surrender previously acquired Ordinary Shares or to have the Company withhold Ordinary Shares relating to this Award in an amount sufficient to satisfy all or a portion of the tax withholding required by law.

(b) Responsibility for Taxes (Only Applicable to Individuals Subject to Tax Laws Outside the U.S.) Regardless of any action the Company or, if different, the Affiliate

 

4


employing or retaining you takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to your participation in the Plan and legally applicable to you (“Tax-Related Items”), you acknowledge that the ultimate liability for all Tax-Related Items is and remains your responsibility and may exceed the amount actually withheld by the Company or the Affiliate employing or retaining you. You further acknowledge that the Company and/or the Affiliate employing or retaining you (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including, but not limited to, the grant, vesting or settlement of the RSUs, the subsequent sale of Ordinary Shares acquired pursuant to such settlement and the receipt of any dividends; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result. Further, if you have become subject to tax in more than one jurisdiction between the RSU Grant Date and the date of any relevant taxable event, as applicable, you acknowledge that the Company and/or the Affiliate employing or retaining you (or formerly employing or retaining you, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

(1) Prior to any relevant taxable or tax withholding event, as applicable, you will pay or make adequate arrangements satisfactory to the Company and/or the Affiliate employing or retaining you to satisfy all Tax-Related Items. In this regard, you authorize the Company and/or the Affiliate employing or retaining you, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following:

(A) withholding from your wages or other cash compensation paid to you by the Company and/or the Affiliate employing or retaining you; or

(B) withholding from proceeds of the sale of Ordinary Shares acquired upon settlement of the RSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization); or

(C) withholding in Ordinary Shares to be issued upon settlement of the RSUs.

(2) To avoid negative accounting treatment, the Company may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in Ordinary Shares, for tax purposes, you are deemed to have been issued the full number of Ordinary Shares subject to the vested RSUs, notwithstanding that a number of the Ordinary Shares are held back solely for the purpose of paying the Tax-Related Items.

(3) Finally, you shall pay to the Company or the Affiliate employing or retaining you any amount of Tax-Related Items that the Company or the Affiliate employing or retaining you may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the Ordinary Shares or the proceeds of the sale of Ordinary Shares, if you fail to comply with your obligations in connection with the Tax-Related Items.

 

5


2.8 Compliance with Applicable Law. The issuance of Ordinary Shares will be subject to and conditioned upon compliance by the Company and you, including any written representations, warranties and agreements as the Administrator may request of you for compliance with all (i) applicable U.S. state and federal laws and regulations, (ii) applicable laws of the country where you reside pertaining to the issuance or sale of Ordinary Shares, and (iii) applicable requirements of any stock exchange or automated quotation system on which the Company’s Ordinary Shares may be listed or quoted at the time of such issuance or transfer. Notwithstanding any other provision of this Agreement, the Company shall have no obligation to issue any Ordinary Shares under this Agreement if such issuance would violate any applicable law or any applicable regulation or requirement of any securities exchange or similar entity.

2.9 Code Section 409A (Only Applicable to Individuals Subject to U.S. Federal Tax Laws)

(a) RSUs (other than RSUs that continue to vest by reason of Section 1.3(b) or Section 1.3(c)) and dividend equivalents payable under this Agreement are intended to be exempt from Code Section 409A under the exemption for short-term deferrals. Accordingly, RSUs (other than RSUs that continue to vest by reason of your Involuntary Termination for Economic Reasons) will be settled and dividend equivalents will be paid no later than the 15th day of the third month following the later of (i) the end of your taxable year in which the RSU Vesting Date occurs, or (ii) the end of the fiscal year of the Company in which the RSU Vesting Date occurs.

(b) RSUs that continue to vest by reason of Section 1.3(b) or Section 1.3(c) are subject to the provisions of this subsection (b). Any distribution in settlement of such RSUs will occur provided your Involuntary Termination for Economic Reasons constitutes a “separation from service” as defined in Treasury Regulation §1.409A-1(h). If the Company determines that you are a “specified employee” as defined in Code Section 409A (i.e., an officer with annual compensation above $130,000 (as adjusted for inflation), a five-percent owner of the Company or a one-percent owner with annual compensation in excess of $150,000), distribution in settlement of any such RSUs that would be payable within six months of your separation from service shall be delayed to the first business day following the six-month anniversary of your separation from service. Any distribution in settlement of such RSUs that would be made more than six months after your separation from service (without application of the six-month delay) shall not be subject to the six-month delay described in this subsection.

2.10 Data Privacy.

(a) U.S. Data Privacy Rules (Only Applicable if this Award is Subject to U.S. Data Privacy Laws). By entering into this Agreement and accepting this Award, you (a) explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of any of your personal data that is necessary to facilitate the implementation, administration and management of the Award and the Plan, (b) understand that the Company may, for the purpose of implementing, administering and managing the Plan, hold certain

 

6


personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, and details of all awards or entitlements to Shares granted to you under the Plan or otherwise (“Personal Data”), (c) understand that Personal Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, including any broker with whom the Shares issued upon vesting of the Award may be deposited, and that these recipients may be located in your country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than your country, (d) waive any data privacy rights you may have with respect to the data, and (e) authorize the Company, its Affiliates and its agents, to store and transmit such information in electronic form.

(b) Non-U.S. Data Privacy Rules (Only Applicable if this Award is Subject to Data Privacy Laws Outside of the U.S.)

(1) By entering into this Agreement and accepting this Award, you hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Agreement and any other RSU grant materials by and among, as applicable, the Affiliate employing or retaining you, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.

(2) You understand that the Company and the Affiliate employing or retaining you may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Ordinary Shares or directorships held in the Company, details of all RSUs or any other entitlement to Ordinary Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the exclusive purpose of implementing, administering and managing the Plan (“Data”).

(3) You understand that Data will be transferred to legal counsel or a broker or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. You understand that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than your country of residence. You understand that if you reside outside the United States, you may request a list with the names and addresses of any potential recipients of the Data by contacting your local or Company human resources representative. You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan. You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan. You understand that if you reside outside the United States, you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local or Company human resources representative. You understand, however, that refusing or withdrawing your consent may affect your ability to participate in the Plan. For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local or Company human resources representative.

 

7


2.11 Successors and Assigns. This Agreement shall be binding upon any or all successors and assigns of the Company.

2.12 Applicable Law. This Agreement shall be governed by and construed and enforced in accordance with the applicable Code provisions to the maximum extent possible and otherwise by the laws of the State of Michigan without regard to principals of conflict of laws, provided that if you are a foreign national or employed outside the United States, this Agreement shall be governed by and construed and enforced in accordance with applicable foreign law to the extent that such law differs from the Code and Michigan law. Any proceeding related to or arising out of this Agreement shall be commenced, prosecuted or continued in the Circuit Court in Kent County, Michigan located in Grand Rapids, Michigan or in the United Stated District Court for the Western District of Michigan, and in any appellate court thereof.

2.13 Forfeiture of RSUs. If the Company, as a result of misconduct, is required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws, then (a) if your incentive or equity-based compensation is subject to automatic forfeiture due to such misconduct and restatement under Section 304 of the Sarbanes-Oxley Act of 2002, or (b) the Committee determines you either knowingly engaged in or failed to prevent the misconduct, or your actions or inactions with respect to the misconduct and restatement constituted gross negligence, you shall (i) be required to reimburse the Company the amount of any payment (including dividend equivalents) relating to any RSUs earned or accrued during the twelve month period following the first public issuance or filing with the SEC (whichever first occurred) of the financial document embodying such financial reporting requirement, and (ii) all outstanding RSUs (including related dividend equivalents) that have not yet been settled shall be immediately forfeited. In addition, Ordinary Shares acquired under this Agreement, and any gains or profits on the sale of such Ordinary Shares, shall be subject to any “clawback” or recoupment policy later adopted by the Company.

2.14 Special Rules for Non-U.S. Grantees (Only Applicable if You Reside Outside of the U.S.)

(a) Nature of Grant. In accepting the grant, you acknowledge, understand and agree that:

(1) the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, except as otherwise provided in the Plan;

(2) the grant of the RSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted repeatedly in the past;

(3) all decisions with respect to future RSU grants, if any, will be at the sole discretion of the Company;

 

8


(4) you are voluntarily participating in the Plan;

(5) the RSUs and the Ordinary Shares subject to the RSUs are an extraordinary item and which is outside the scope of your employment or service contract, if any;

(6) the RSUs and the Ordinary Shares subject to the RSUs are not intended to replace any pension rights or compensation;

(7) the RSUs and the Ordinary Shares subject to the RSUs are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the Affiliate employing or retaining you or any other Affiliate;

(8) the grant and your participation in the Plan will not be interpreted to form an employment or service contract with the Company or any Affiliate;

(9) the future value of the underlying Ordinary Shares is unknown, indeterminable and cannot be predicted with certainty;

(10) no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs resulting from your Termination Date (for any reason whatsoever, whether or not later found to be invalid and whether or not in breach of employment laws in the jurisdiction where you are employed or rendering services, or the terms of your employment agreement, if any), and in consideration of the grant of the RSUs to which you are otherwise not entitled, you irrevocably agree never to institute any claim against the Company or the Affiliate employing or retaining you, waive your ability, if any, to bring any such claim, and release the Company and the Affiliate employing or retaining you from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, you shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claim; and

(11) you acknowledge and agree that neither the Company, the Affiliate employing or retaining you nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between the currency of the country in which you reside and the United States Dollar that may affect the value of the RSUs or of any amounts due to you pursuant to the settlement of the RSUs or the subsequent sale of any Ordinary Shares acquired upon settlement.

(b) Appendix. Notwithstanding any provisions in this Agreement, the RSU grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement for your country. Moreover, if you relocate to one of the countries included in the Appendix, the special terms and conditions for such country will apply to you, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan. If you relocate to the United States, the special terms and conditions in the Appendix will apply, or cease to apply, to you, to the extent the Company determines that the application or otherwise of such provisions is necessary or advisable in order to facilitate the administration of the Plan. The Appendix constitutes part of this Agreement.

 

9


(c) Imposition of Other Requirements. The Company reserves the right to impose other requirements on your participation in the Plan, on the RSUs and on any Ordinary Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

2.15 Noncompetition and Nonsolicitation.

(a) Noncompetition. During your employment with the Company and its Affiliates and for a twelve (12) month period following your Termination Date (the “Restricted Period”), you shall not (i) directly or indirectly, without the prior written consent of the Company, engage in or invest as an owner, partner, stockholder, licensor, director, officer, agent or consultant for any Person that conducts a business that is in competition with a business conducted by the Company or any of its Affiliates anywhere in the world; or (ii) accept employment or an engagement for the provision of services in any capacity, including as an employee, director, consultant or advisor, directly or indirectly, with any Person that conducts a business that is in competition with a business conducted by the Company or any of its Affiliates anywhere in the world except where prohibited by local law. For purposes hereof, conducting a business that is in competition with a business conducted by the Company or any of its Affiliates shall include the sale, manufacture, distribution or research and development of any product or service that is similar to a product or service sold, distributed, marketed or being researched or developed (including through a joint venture or investment in another entity) by the Company or any of its Affiliates, including store brand and value brand OTC drug or nutritional products, extended topical generic prescription pharmaceutical products, infant nutrition products, oral care products, and any other product or products that the Company or an Affiliate is marketing or actively planning to market during your employment with the Company and during the one-year period following your Termination Date. If there is a completed sale, transfer or other disposition of the Perrigo Prescription Pharmaceutical business during the Restricted Period, this Section 2.15(a) will not apply to the Perrigo Prescription Pharmaceutical business. Notwithstanding the foregoing, nothing in this provision shall prevent you from passively owning two percent (2%) or less of the outstanding securities of any class of any company listed on a national securities exchange or quoted on an automated quotation system. You may make a written request in writing to the CHRO of the Company for an exception to this Section 2.15(a) and such exception will not be unreasonably withheld.

(b) Nonsolicitation of Service Providers. During your employment with the Company and its Affiliates and for the duration of the Restricted Period, you shall not, directly or indirectly, without the prior written consent of the Company, (i) actively solicit, recruit or hire any Person who is at such time, or who at any time during the 12-month period prior to such solicitation or hiring had been, an employee or consultant of the Company or any of its Affiliates, (ii) solicit or encourage any employee of the Company or any of its Affiliates to leave the employment of the Company or any of its Affiliates or (iii) interfere with the relationship of the Company or any of its Affiliates with any Person or entity who or that is employed by or otherwise engaged to perform services for the Company or any of its Affiliates except where prohibited by local law.

 

10


(c) Nonsolicitation of Clients. During your employment with the Company and its Affiliates and for the duration of the Restricted Period, you shall not, directly or indirectly, alone or in association with any other Person, without the prior written consent of the Company, (i) induce or attempt to induce any client, customer (whether former or current), supplier, licensee, franchisee, joint venture partner or other business relation of the Company or any of its Affiliates (collectively, “Clients”) to cease doing business with the Company or any such Affiliate, (ii) divert all or any portion of a Client’s business with the Company to any competitor of the Company or any such Affiliate, or (iii) in any way interfere with the relationship between any Client, on the one hand, and the Company or any such Affiliate, on the other hand except where prohibited by local law.

(d) Remedies and Injunctive Relief. You acknowledge that a violation by you of any of the covenants contained in this Section 2.15 would cause irreparable damage to the Company and its Affiliates in an amount that would be material but not readily ascertainable, and that any remedy at law (including the payment of damages) would be inadequate. Accordingly, you agree that, notwithstanding any provision of this Agreement to the contrary, in addition to any other damages it is able to show, the Company and its Affiliates shall be entitled (without the necessity of showing economic loss or other actual damage) to injunctive relief (including temporary restraining orders, preliminary injunctions and permanent injunctions), without posting a bond, in any court of competent jurisdiction for any actual or threatened breach of any of the covenants set forth in this Section 2.15 in addition to any other legal or equitable remedies it may have. In addition, in the event of your Willful Restrictive Covenant Breach (as defined in this Section 2.15), (i) all of your rights under this Agreement, whether or not vested, shall terminate immediately, and (ii) any Shares, cash or other property paid or delivered to you pursuant to this Agreement shall be forfeited and you shall be required to repay such Shares, cash or other property to the Company, no later than thirty (30) calendar days after the Company makes demand to you for repayment. For purposes of this Agreement, “Willful Restrictive Covenant Breach” means your material breach of any of the covenants set forth in this Section 2.15 which you knew, or with due inquiry, should have known, would constitute such a material breach. The preceding sentences of this Section 2.15 shall not be construed as a waiver of the rights that the Company and its Affiliates may have for damages under this Agreement or otherwise, and all such rights shall be unrestricted. The Restricted Period shall be tolled during (and shall be deemed automatically extended by) any period during which you are in violation of the provisions of Section 2.15(a), (b) or (c), as applicable. In the event that a court of competent jurisdiction determines that any provision of this Section 2.15 is invalid or more restrictive than permitted under the governing law of such jurisdiction, then, only as to enforcement of this Section 2.15 within the jurisdiction of such court, such provision shall be interpreted and enforced as if it provided for the maximum restriction permitted under such governing law.

 

11


(e) Acknowledgments.

(1) You acknowledge that the Company and its Affiliates have expended and will continue to expend substantial amounts of time, money and effort to develop business strategies, employee, customer and other relationships and goodwill to build an effective organization. You acknowledge that the Company and its Affiliates have a legitimate business interest in and right to protect its goodwill and employee, customer and other relationships, and that the Company and its Affiliates could be seriously damaged by the loss or deterioration of its employee, customer and other relationships. You further acknowledge that the Company and its Affiliates are entitled to protect and preserve the going concern value of the Company and its Affiliates to the extent permitted by law.

(2) In light of the foregoing acknowledgments, you agree that the covenants contained in this Agreement are reasonable and properly required for the adequate protection of the businesses and goodwill of the Company and its Affiliates. You further acknowledge that, although your compliance with the covenants contained in this Agreement may prevent you from earning a livelihood in a business similar to the business of the Company and its Affiliates, your experience and capabilities are such that you have other opportunities to earn a livelihood and adequate means of support for you and your dependents.

(3) In light of the acknowledgements contained in this Section 2.15, you agree not to challenge or contest the reasonableness, validity or enforceability of any limitations on, and obligations of, you contained in this Section 2.15.

****

We look forward to your continuing contribution to the growth of the Company. Please acknowledge your receipt of the Plan and this Award.

 

Very truly yours,
/s/ Orlando Ashford
Orlando Ashford
Chairman of the Board

 

12

EX-101.SCH 5 prgo-20230608.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.DEF 6 prgo-20230608_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 7 prgo-20230608_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Entity Tax Identification Number Entity Tax Identification Number City Area Code City Area Code Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity File Number Entity File Number Entity Incorporation State Country Code Entity Incorporation State Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, Country Entity Address, Country Entity Address, Postal Zip Code Entity Address, Postal Zip Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Document And Entity Information [Table] Document And Entity Information [Table] Document And Entity Information [Line Items] Document And Entity Information [Line Items] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Ordinary Shares 0001 Par Value [Member] Ordinary Shares 0001 Par Value [Member] A 39 Senior Note Due 2024 [Member] A 39 Senior Note Due 2024 [Member] M 4.375 Notes Due 2026 [Member] M 4.375 Notes Due 2026 [Member] A 313 Senior Note Due 2030 [Member] A 313 Senior Note Due 2030 [Member] M 5.300 Notes Due 2043 [Member] M 5.300 Notes Due 2043 [Member] M 4.900 Notes Due 2044 [Member] M 4.900 Notes Due 2044 [Member] EX-101.PRE 8 prgo-20230608_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information
Jun. 08, 2023
Document And Entity Information [Line Items]  
Entity Registrant Name PERRIGO Co plc
Entity Tax Identification Number 00-0000000
City Area Code 1
Amendment Flag false
Entity Central Index Key 0001585364
Document Type 8-K
Document Period End Date Jun. 08, 2023
Entity File Number 001-36353
Entity Incorporation State Country Code L2
Entity Address, Address Line One The Sharp Building
Entity Address, Address Line Two Hogan Place
Entity Address, City or Town Dublin 2
Entity Address, Country IE
Entity Address, Postal Zip Code D02 TY74
Local Phone Number 7094000
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Ordinary Shares 0001 Par Value [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Ordinary shares, €0.001 par value
Trading Symbol PRGO
Security Exchange Name NYSE
A 39 Senior Note Due 2024 [Member]  
Document And Entity Information [Line Items]  
Security 12b Title 3.900% Notes due 2024
Trading Symbol PRGO24
Security Exchange Name NYSE
M 4.375 Notes Due 2026 [Member]  
Document And Entity Information [Line Items]  
Security 12b Title 4.375% Notes due 2026
Trading Symbol PRGO26
Security Exchange Name NYSE
A 313 Senior Note Due 2030 [Member]  
Document And Entity Information [Line Items]  
Security 12b Title 4.400% Notes due 2030
Trading Symbol PRGO30
Security Exchange Name NYSE
M 5.300 Notes Due 2043 [Member]  
Document And Entity Information [Line Items]  
Security 12b Title 5.300% Notes due 2043
Trading Symbol PRGO43
Security Exchange Name NYSE
M 4.900 Notes Due 2044 [Member]  
Document And Entity Information [Line Items]  
Security 12b Title 4.900% Notes due 2044
Trading Symbol PRGO44
Security Exchange Name NYSE
XML 10 d505583d8k_htm.xml IDEA: XBRL DOCUMENT 0001585364 2023-06-08 2023-06-08 0001585364 prgo:OrdinaryShares0001ParValueMember 2023-06-08 2023-06-08 0001585364 prgo:A39SeniorNoteDue2024Member 2023-06-08 2023-06-08 0001585364 prgo:M4.375NotesDue2026Member 2023-06-08 2023-06-08 0001585364 prgo:A313SeniorNoteDue2030Member 2023-06-08 2023-06-08 0001585364 prgo:M5.300NotesDue2043Member 2023-06-08 2023-06-08 0001585364 prgo:M4.900NotesDue2044Member 2023-06-08 2023-06-08 PERRIGO Co plc 00-0000000 1 false 0001585364 8-K 2023-06-08 001-36353 L2 The Sharp Building Hogan Place Dublin 2 IE D02 TY74 1 7094000 false false false false Ordinary shares, €0.001 par value PRGO NYSE 3.900% Notes due 2024 PRGO24 NYSE 4.375% Notes due 2026 PRGO26 NYSE 4.400% Notes due 2030 PRGO30 NYSE 5.300% Notes due 2043 PRGO43 NYSE 4.900% Notes due 2044 PRGO44 NYSE false EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 7 23 1 false 6 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:CityAreaCode, dei:EntityRegistrantName - d505583d8k.htm 7 d505583d8k.htm d505583dex101.htm d505583dex102.htm d505583dex103.htm prgo-20230608.xsd prgo-20230608_def.xml prgo-20230608_lab.xml prgo-20230608_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d505583d8k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 39 }, "contextCount": 7, "dts": { "definitionLink": { "local": [ "prgo-20230608_def.xml" ] }, "inline": { "local": [ "d505583d8k.htm" ] }, "labelLink": { "local": [ "prgo-20230608_lab.xml" ] }, "presentationLink": { "local": [ "prgo-20230608_pre.xml" ] }, "schema": { "local": [ "prgo-20230608.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd" ] } }, "elementCount": 34, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 5, "total": 5 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 6, "memberStandard": 0, "nsprefix": "prgo", "nsuri": "http://www.perrigo.com/20230608", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d505583d8k.htm", "contextRef": "duration_2023-06-08_to_2023-06-08", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d505583d8k.htm", "contextRef": "duration_2023-06-08_to_2023-06-08", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 6, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "prgo_A313SeniorNoteDue2030Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "A 313 Senior Note Due 2030 [Member]", "terseLabel": "A 313 Senior Note Due 2030 [Member]" } } }, "localname": "A313SeniorNoteDue2030Member", "nsuri": "http://www.perrigo.com/20230608", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "prgo_A39SeniorNoteDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "A 39 Senior Note Due 2024 [Member]", "terseLabel": "A 39 Senior Note Due 2024 [Member]" } } }, "localname": "A39SeniorNoteDue2024Member", "nsuri": "http://www.perrigo.com/20230608", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "prgo_DocumentAndEntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Line Items]", "terseLabel": "Document And Entity Information [Line Items]" } } }, "localname": "DocumentAndEntityInformationLineItems", "nsuri": "http://www.perrigo.com/20230608", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "prgo_DocumentAndEntityInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Table]", "terseLabel": "Document And Entity Information [Table]" } } }, "localname": "DocumentAndEntityInformationTable", "nsuri": "http://www.perrigo.com/20230608", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "prgo_M4.375NotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "M 4.375 Notes Due 2026 [Member]", "terseLabel": "M 4.375 Notes Due 2026 [Member]" } } }, "localname": "M4.375NotesDue2026Member", "nsuri": "http://www.perrigo.com/20230608", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "prgo_M4.900NotesDue2044Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "M 4.900 Notes Due 2044 [Member]", "terseLabel": "M 4.900 Notes Due 2044 [Member]" } } }, "localname": "M4.900NotesDue2044Member", "nsuri": "http://www.perrigo.com/20230608", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "prgo_M5.300NotesDue2043Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "M 5.300 Notes Due 2043 [Member]", "terseLabel": "M 5.300 Notes Due 2043 [Member]" } } }, "localname": "M5.300NotesDue2043Member", "nsuri": "http://www.perrigo.com/20230608", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "prgo_OrdinaryShares0001ParValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ordinary Shares 0001 Par Value [Member]", "terseLabel": "Ordinary Shares 0001 Par Value [Member]" } } }, "localname": "OrdinaryShares0001ParValueMember", "nsuri": "http://www.perrigo.com/20230608", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.perrigo.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 18 0001193125-23-163039-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-163039-xbrl.zip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